Second line medication for Crohn's disease

RX_CROHN_2NDLINE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — L04AX\|L01BB02 1 out of 7 registries used, show all original rules.	31288
4. Check minimum number of events Min. number of events 3	31288
5. Include endpoints None	31288
6. Filter based on genotype QC (FinnGen only)	30338

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF5

NAME	RX_CROHN_2NDLINE
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	L04AX\|L01BB02
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Second line medication for Crohn's disease based on the number of shared cases.

Similar with more cases:

Any prescribed medicine buy

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	143874	84541	58823
Only index persons	136668	80893	55775
Unadjusted period prevalence (%)
Whole population	2.10	2.42	1.64
Only index persons	2.63	2.97	2.13
Median age at first event (years)
Whole population	53.34	53.97	52.43
Only index persons	53.04	53.70	52.07

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	30338	18768	11570
Unadjusted period prevalence (%)	6.14	6.66	5.30
Median age at first event (years)	53.31	52.13	55.21

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
31288: Matched controls
312733

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R4110

NOMESCO Finland

Physiotherapy

1.7

322.8

8294

55225

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

320.7

12974

96563

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.0

320.7

1461

4971

L40.8

ICD-10 Finland

Other psoriasis

7.6

320.5

454

602

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

3.2

319.4

1294

4109

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

7.2

318.3

474

665

TNH10

NOMESCO Finland

Joint puncture, ankle joint or foot joint

28.2

317.1

213

WW200

NOMESCO Finland

Immunization

3.5

314.8

1120

3278

9522

FHL

Synovectomy

26.0

314.1

217

L01CB

ATC

Podophyllotoxin derivatives

30.5

309.9

203

D07AC13

ATC

mometasone; topical

1.6

309.6

8754

59627

NDG30

NOMESCO Finland

Fusion of wrist, total

21.3

307.7

462

220

3006

Kela drug reimbursment

Baricitinib

71.8

307.7

292

TGC00

NOMESCO Finland

Bronchial lavation

3.9

307.7

1000

2643

A07EC02

ATC

mesalazine; oral, rectal

9.8

307.7

4974

5900

L04AC13

ATC

ixekizumab; parenteral

46.8

307.7

370

K51.5

ICD-10 Finland

Left sided colitis

15.3

307.7

2972

2126

D05AX52

ATC

calcipotriol, combinations; topical

5.7

307.7

3457

6652

L04AX03

ATC

methotrexate; systemic

364.3

307.7

23009

2368

D07XC01

ATC

betamethasone; topical

2.8

307.7

4853

19027

M05BA04

ATC

alendronic acid; oral

3.9

307.7

3732

10414

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

4.7

307.7

886

1944

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

3.3

307.7

1393

4407

4AA12, ,

NOMESCO Finland

108.5

307.7

460

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

4.9

307.7

16954

60584

L40.0

ICD-10 Finland

Psoriasis vulgaris

7.6

307.7

3198

4617

K50.8

ICD-10 Finland

Other Crohn disease

29.1

307.7

1997

731

298, ,

Kela drug reimbursment

84.6

307.7

277

253, ,

Kela drug reimbursment

43.2

307.7

325

71239

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD

13.8

307.7

439

322

UJF32

NOMESCO Finland

Coloscopy

2.4

307.7

9730

48927

A02BC02

ATC

pantoprazole; systemic

2.2

307.7

22403

165979

L04AB05

ATC

certolizumab pegol; parenteral

56.0

307.7

653

119

L01BB01, ,

ATC

190.3

307.7

283

E000001, ,

ATC

1.8

307.7

6325

38473

H02AB09

ATC

hydrocortisone; systemic

4.6

307.7

1179

2631

M35.3

ICD-10 Finland

Polymyalgia rheumatica

4.3

307.7

1723

4174

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

65.3

307.7

8919

1897

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

8.8

307.7

844

977

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

307.7

13446

96184

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

9.1

307.7

1396

1593

L04AX01

ATC

azathioprine; systemic

115.6

307.7

8915

1074

L04AA13

ATC

[U] leflunomide

53.1

307.7

3903

837

L20

ICPC

Joint symptom/complaint NOS

3.2

307.7

1522

4875

RT271, ,

NOMESCO Finland

28.2

307.7

224

L04AA17

ATC

[U] adalimumab

57.9

307.7

406

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.9

307.7

3710

13710

L04AA01

ATC

[U] ciclosporin

22.8

307.7

1535

707

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

9.8

307.7

1938

2098

H26.3

ICD-10 Finland

Drug-induced cataract

10.8

307.7

405

381

L40.5

ICD-10 Finland

Arthropathic psoriasis

39.3

307.7

2336

640

R50.9

ICD-10 Finland

Fever, unspecified

2.1

307.7

5079

26281

L04AB02

ATC

infliximab; parenteral

80.0

307.7

666

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

26.3

307.7

9796

5337

L04AA24

ATC

abatacept; parenteral

91.2

307.7

617

L04AC14

ATC

sarilumab; systemic

116.6

307.7

174

H02AB04

ATC

methylprednisolone; systemic

2.5

307.7

5509

24740

134

Kela drug reimbursment

General erythroderma

19.0

307.7

282

150

N07XX09

ATC

[U] dimethyl fumarate

43.4

307.7

271

L04AX05

ATC

pirfenidone; oral

199.4

307.7

355

109

Kela drug reimbursment

Multiple sclerosis

7.4

307.7

716

989

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

8.3

307.7

755

926

L04AB06

ATC

golimumab; parenteral

54.3

307.7

1222

234

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

23.9

307.7

346

146

N02AX02

ATC

tramadol; systemic, rectal

1.7

307.7

13287

93676

TNC11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in elbow joint

36.1

307.7

336

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

14.3

307.7

629

449

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

21.6

307.7

499

235

L88

ICPC

Rheumatoid/seropositive arthritis

52.5

307.7

6614

1588

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

37.5

307.7

1668

469

D05AX03

ATC

calcitriol; topical

8.2

307.7

813

1011

P01BA02

ATC

hydroxychloroquine; oral

28.8

307.7

11892

6513

K75.4

ICD-10 Finland

Autoimmune hepatitis

26.6

307.7

225

M05BA07

ATC

risedronic acid; oral

4.0

307.7

1138

2956

M07.0*L40.5

ICD-10 Finland

Distal interphalangeal psoriatic arthropathy

27.5

307.7

292

107

M01AH05

ATC

etoricoxib; oral

1.6

307.7

19136

154556

O99.6

ICD-10 Finland

Diseases of the digestive system complicating pregnancy, childbirth and the puerperium

10.1

307.7

487

488

M25.5

ICD-10 Finland

Pain in joint

2.0

307.7

11235

68848

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

69.1

307.7

5301

921

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.2

307.7

18157

94256

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

5.6

307.7

986

1814

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

307.7

7083

40810

D07AC01

ATC

betamethasone; topical

1.8

307.7

11591

77043

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

9.0

307.7

1773

2068

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

12.3

307.7

646

533

127

Kela drug reimbursment

Transplant complication

5.5

307.7

831

1535

XX9XE

NOMESCO Finland

Other ultrasound examination

19.6

307.7

864

452

M01CB01

ATC

sodium aurothiomalate; parenteral

38.8

307.7

1620

440

L04AA29

ATC

[U] tofacitinib

69.6

307.7

433

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

74.6

307.7

1247

174

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.2

307.7

3067

14740

K50.1

ICD-10 Finland

Crohn disease of large intestine

25.8

307.7

1464

593

3042, ,

Kela drug reimbursment

42.6

307.7

325

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

39.5

307.7

1304

344

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

14.0

307.7

385

278

A07EA02

ATC

hydrocortisone; rectal

10.5

307.7

1799

1813

K51.8

ICD-10 Finland

Other ulcerative colitis

13.2

307.7

1234

973

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

5.7

307.7

817

1462

WZC30

NOMESCO Finland

Teaching

1.9

307.7

4934

27924

J01MA02

ATC

ciprofloxacin; systemic

1.6

307.7

11288

80735

NH3AE

NOMESCO Finland

Feet ultrasound examination

22.4

307.7

287

129

3029

Kela drug reimbursment

Upadacitinib

77.7

307.7

285

M07.4*K50.9

ICD-10 Finland

Arthropathy in Crohn's disease [regional enteritis]

54.5

307.7

265

M45

ICD-10 Finland

Ankylosing spondylitis

10.4

307.7

1719

1743

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

35.7

307.7

4151

1334

H02AB07

ATC

prednisone; oral

4.1

307.7

7183

21087

D07AD01

ATC

clobetasol; topical

2.2

307.7

5913

30339

M01AH01

ATC

celecoxib; oral

2.0

307.7

5756

32220

K50

ICD-10 Finland

Crohn disease [regional enteritis]

24.5

307.7

394

163

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

6.8

307.7

919

1392

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

43.5

307.7

3907

1022

M06.4

ICD-10 Finland

Inflammatory polyarthropathy

21.8

307.7

366

170

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.5

307.7

3413

14492

H20.1

ICD-10 Finland

Chronic iridocyclitis

9.1

307.7

720

810

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

10.4

307.7

1015

1006

H02AB06

ATC

prednisolone; systemic

7.5

307.7

24403

100550

L04AC05

ATC

ustekinumab; parenteral

61.4

307.7

691

115

RT272, ,

NOMESCO Finland

22.5

307.7

310

139

L40

ICD-10 Finland

Psoriasis

5.1

307.7

932

1870

NF1AA

NOMESCO Finland

Hip X-ray examination

2.3

307.7

2672

12052

377

Kela drug reimbursment

Apremilast and dimethyl fumarate (psoriasis)

31.0

307.7

344

112

M31.3

ICD-10 Finland

Wegener granulomatosis

28.6

307.7

323

114

A07EA06

ATC

budesonide; oral, local oral

12.4

307.7

3790

3428

L40.9

ICD-10 Finland

Psoriasis, unspecified

5.6

307.7

811

1468

M07.5*K51.9

ICD-10 Finland

Arthropathy in ulcerative colitis

33.8

307.7

328

J01DB01

ATC

cefalexin; oral

1.9

307.7

25895

225224

M13.8

ICD-10 Finland

Other specified arthritis

8.1

307.7

621

776

TNG10

NOMESCO Finland

Puncture of knee

22.5

307.7

1195

550

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

23.4

307.7

9072

5375

L04AA33

ATC

[U] vedolizumab

45.0

307.7

259

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

51.7

307.7

2963

632

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.7

307.7

2138

6134

M35.1

ICD-10 Finland

Other overlap syndromes

16.0

307.7

362

228

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

7.0

307.7

935

1361

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

5.4

307.7

3910

8002

L04AD01

ATC

ciclosporin; systemic

16.4

307.7

1913

1239

K50.9

ICD-10 Finland

Crohn disease, unspecified

20.7

307.7

1675

852

D94

ICPC

Chronic enteritis/ulcerative colitis

12.6

307.7

572

463

K51

ICD-10 Finland

Ulcerative colitis

10.1

307.7

736

747

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

15.2

307.7

1746

1211

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

30.8

307.7

1080

363

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

15.6

307.7

674

441

L04AB01

ATC

etanercept; parenteral

58.4

307.7

2498

464

256, ,

Kela drug reimbursment

70.7

307.7

308

C90.0

ICD-10 Finland

Multiple myeloma

14.5

307.7

741

524

NDL52

NOMESCO Finland

Tenosynovectomy of hand

14.3

307.7

528

375

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

21.5

307.7

1005

482

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

307.7

12540

90910

UJF30

NOMESCO Finland

Ileoscopy through colon

3.6

307.7

5059

15867

J01FF01

ATC

clindamycin; systemic

1.7

307.7

8327

55470

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.2

307.7

4123

19931

JF1DG

NOMESCO Finland

Small bowel very extensive MRI with with high intensity magnet

24.5

307.7

406

168

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

5.6

307.7

2147

4075

L04AA32

ATC

apremilast; oral

31.6

307.7

319

102

NH3EA

NOMESCO Finland

Feet X-ray examination with load

13.0

307.7

1802

1462

L04AC18

ATC

risankizumab; parenteral

59.9

307.7

244

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

307.7

4400

23334

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

4.0

307.7

1834

4778

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

6.1

307.7

6438

12807

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

44.4

307.7

919

213

ZX120

NOMESCO Finland

Intravenous

4.2

307.7

4939

13403

R4120

NOMESCO Finland

Occupational therapy

3.0

307.7

2657

9273

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

69.5

307.7

1661

252

UJF92

NOMESCO Finland

Capsular endoscopy

4.9

307.7

1101

2315

TND10

NOMESCO Finland

Joint puncture, wrist or finger joint

47.1

307.7

340

L04AA06

ATC

mycophenolic acid; systemic

7.0

307.7

1242

1842

ZX140

NOMESCO Finland

Intra articular

14.9

307.7

633

432

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

6.8

307.7

816

1229

M13.9

ICD-10 Finland

Arthritis, unspecified

8.7

307.7

6283

8730

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

68.5

307.7

5005

867

M01AC06

ATC

meloxicam; systemic, rectal

1.7

307.7

11009

77035

M13.0

ICD-10 Finland

Polyarthritis, unspecified

11.1

307.7

896

830

TQW80

NOMESCO Finland

Local dermatologic skincare

4.0

307.7

1149

2975

L04AC16

ATC

guselkumab; systemic

52.3

307.7

244

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

4.9

307.7

798

1645

7140B

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SERONEGATIVA]

21.4

307.7

354

167

L04AG05

ATC

vedolizumab; parenteral

44.4

307.7

238

L04AA44

ATC

[U] upadacitinib

77.6

307.7

239

M08.9

ICD-10 Finland

Juvenile arthritis, unspecified

35.1

307.7

237

L04AX04

ATC

lenalidomide; oral

130.5

307.7

677

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

8.2

307.7

665

822

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

12.2

307.7

897

757

291

Kela drug reimbursment

Tofacitinib

85.1

307.7

362

D05AX02

ATC

calcipotriol; topical

5.9

307.7

2184

3946

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

3.2

307.7

2650

8765

L01BB02

ATC

mercaptopurine; oral

73.2

307.7

1888

274

356

Kela drug reimbursment

Nintedanib and pirfenidone

20.9

307.7

349

169

G35

ICD-10 Finland

Multiple sclerosis

5.2

307.7

814

1603

L04AK01

ATC

leflunomide; oral

36.9

307.7

680

188

293

Kela drug reimbursment

Baricitinib

77.8

307.7

270

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

12.9

307.7

1850

1522

M01CB03

ATC

auranofin; oral

24.4

307.7

701

294

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

307.7

6700

41814

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

40.2

307.7

3122

860

NH1AE

NOMESCO Finland

Ankle joint ultrasound examination

15.1

307.7

674

456

D05BB02

ATC

acitretin; oral

7.6

307.7

1493

2052

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

26.3

307.7

586

227

4AB02, ,

NOMESCO Finland

120.1

307.7

520

319

Kela drug reimbursment

Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)

42.1

307.7

693

168

L01BA01

ATC

methotrexate; systemic

72.7

307.7

6490

1122

A07EC01

ATC

sulfasalazine; oral, rectal

31.6

307.7

12045

6073

WZA10

NOMESCO Finland

Extensive medical or dental certificate

10.4

307.7

1091

1084

K50.0

ICD-10 Finland

Crohn disease of small intestine

22.2

307.7

1754

835

M07.3

ICD-10 Finland

Other psoriatic arthropathies

49.5

307.7

1439

304

NG1DA

NOMESCO Finland

X-ray of knees

5.9

307.7

930

1617

L04AC10

ATC

secukinumab; parenteral

36.8

307.7

546

151

L04AF03

ATC

upadacitinib; oral

90.2

307.7

224

L04AA11

ATC

[U] etanercept

52.2

307.7

463

L04AB04

ATC

adalimumab; parenteral

67.5

307.7

3841

647

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

22.4

307.7

592

269

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

307.7

9373

56521

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

65.8

307.7

19463

7629

E0000UV, ,

ATC

1.9

307.7

13888

94095

M08.4

ICD-10 Finland

Pauciarticular juvenile arthritis

42.9

307.7

623

148

M06

ICD-10 Finland

Other rheumatoid arthritis

44.7

307.7

713

163

153

Kela drug reimbursment

Lenalidomid

91.4

307.7

671

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

11.0

307.7

2811

2776

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

10.2

307.7

506

505

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

6.1

307.7

698

1172

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

7.0

307.7

798

1170

L04AC07

ATC

tocilizumab; parenteral

59.1

307.7

437

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

12.8

307.7

1662

1369

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

17.7

307.7

748

431

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

4.6

307.7

5051

12584

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

9.0

307.7

656

740

284

Kela drug reimbursment

Nintedanib and pirfenidone

21.8

307.7

362

168

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

16.0

307.7

5448

4060

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

6.1

307.7

725

1207

L04AA37

ATC

[U] baricitinib

78.1

307.7

271

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

4.8

307.7

902

1938

M08.0

ICD-10 Finland

Juvenile rheumatoid arthritis

56.8

307.7

619

111

329

Kela drug reimbursment

Lenalidomide

91.0

307.7

502

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

57.5

307.7

576

102

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

25.0

307.7

868

357

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

7.5

307.7

477

641

3005

Kela drug reimbursment

Tofacitinib

70.5

307.7

411

S91

ICPC

Psoriasis

9.3

307.7

560

614

L04AX07

ATC

dimethyl fumarate; oral

222.0

307.7

567

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.1

304.6

3177

15899

XW000

NOMESCO Finland

Bone marrow biopsy

3.0

304.0

1393

4753

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.6

301.4

1888

7589

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.2

301.4

2727

12904

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

5.2

298.4

626

1230

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.4

297.7

2281

10061

9256

FHL

Synovectomy (knee 9311)

30.2

296.8

195

Z3231

NOMESCO Finland

Registered nurse

1.7

296.5

8138

54904

Z3229

NOMESCO Finland

Other healthcare associate professional

2.2

294.2

2635

12412

NA6AA

NOMESCO Finland

Sacro-iliac joint X-ray examination

12.0

293.5

295

247

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.8

292.1

5372

32469

N02BE01

ATC

paracetamol; systemic, rectal

1.9

291.5

27253

244846

NDB78

NOMESCO Finland

Prosthetic replacement of several of finger or metacarpal

42.4

289.3

173

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.7

288.4

1611

6114

Z3226

NOMESCO Finland

Physiotherapist

1.8

286.0

5467

33397

H02AB08

ATC

triamcinolone; systemic

14.0

286.0

262

188

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.5

285.8

1008

2932

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

4.0

285.3

831

2120

M07.0

ICD-10 Finland

Distal interphalangeal psoriatic arthropathy

37.4

283.5

175

R4180

NOMESCO Finland

Podiatric therapy

5.6

282.6

544

989

JFH30

NOMESCO Finland

Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy

21.2

282.3

211

100

L04AF01

ATC

tofacitinib; oral

104.0

281.1

145

ND1AE

NOMESCO Finland

Wrist ultrasound examination

13.4

280.1

264

199

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.2

278.8

2581

12310

M05BX04

ATC

denosumab; parenteral

2.5

275.8

1812

7445

Z94.0

ICD-10 Finland

Kidney transplant status

5.4

274.2

546

1024

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

273.9

13312

102051

9503

FHL

Tendon or tendon sheath cleansing surgery (tenosynovectomy)

16.7

271.8

227

137

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

11.0

269.3

288

265

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.8

267.6

1376

4997

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

264.8

6177

39774

M34.1

ICD-10 Finland

CR(E)ST syndrome

11.7

264.3

271

234

J05AB11

ATC

valaciclovir; oral

1.8

262.6

4395

25748

1XC02, ,

NOMESCO Finland

7.9

261.0

358

457

299, ,

Kela drug reimbursment

58.2

259.0

145

M13.1

ICD-10 Finland

Monoarthritis, not elsewhere classified

5.5

258.9

506

933

J05AB01

ATC

aciclovir; systemic

1.7

254.9

6513

42885

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.2

254.1

2264

10619

NDF10

NOMESCO Finland

Synovectomy of wrist

28.0

252.5

170

4AA33, ,

NOMESCO Finland

52.8

249.0

142

M34.9

ICD-10 Finland

Systemic sclerosis, unspecified

15.1

249.0

219

146

7151

FHL

Kidney transplantation

115.9

248.9

127

WX002

NOMESCO Finland

Sedation and analgesia

1.7

247.4

5511

34976

C10AC01

ATC

colestyramine; oral

3.2

246.0

1018

3269

71200

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Juvenile rheumatoid arthritis

15.2

243.9

214

142

D07AB08

ATC

desonide; topical

1.9

243.8

3333

18281

A02BC03

ATC

lansoprazole; oral

1.6

243.6

8084

56608

NGF15

NOMESCO Finland

Total synovectomy of knee, arthroscopic

5.3

236.9

486

936

RT310, ,

NOMESCO Finland

43.9

236.0

140

RK220, ,

NOMESCO Finland

11.8

235.7

240

205

M12.3

ICD-10 Finland

Palindromic rheumatism

15.0

234.4

207

139

Z2221

NOMESCO Finland

Medical doctor

1.6

228.4

7986

56438

318

Kela drug reimbursment

Teriparatide

9.1

227.9

278

307

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

226.9

8939

64827

M07.2*L40.5

ICD-10 Finland

Psoriatic spondylitis

31.9

226.0

146

A04AA01

ATC

ondansetron; systemic, rectal

2.1

226.0

2482

12599

J01MA12

ATC

levofloxacin; systemic

1.7

223.9

5049

32055

NHG24

NOMESCO Finland

Fusion of subtalar joint and between bones of ankle

7.1

223.6

335

473

M06.3

ICD-10 Finland

Rheumatoid nodule

43.1

223.1

133

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

222.6

3490

19968

9284

FHL

Wrist ossification surgery

33.2

222.4

142

NDB60

NOMESCO Finland

Prosthetic replacement of MCP joint of finger

25.8

222.2

154

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

222.1

3491

19988

B01AB05

ATC

enoxaparin; parenteral

1.5

219.7

8742

63446

NDF60

NOMESCO Finland

Operation for osteochondritis of a joint of hand,v

12.3

219.5

218

179

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

11.4

218.7

228

202

WW300

NOMESCO Finland

Transfer of autologic stem cells

10.5

218.2

240

230

7143C

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[POLYARTHRITIS JUVENILIS SERONEGATIVA]

29.5

217.6

144

S18

ICPC

Laceration/cut

1.5

216.1

12833

100850

M05.3

ICD-10 Finland

Rheumatoid arthritis with involvement of other organs and systems

39.0

216.1

132

B03XA01

ATC

erythropoietin; parenteral

6.6

215.8

350

538

N08.5*M31.3

ICD-10 Finland

Glomerular disorders in Wegener's granulomatosis

36.4

215.4

134

A07EA01

ATC

prednisolone; oral, rectal

7.9

214.9

295

377

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.6

214.5

1262

4905

D02AE01

ATC

carbamide; topical

2.2

214.4

2020

9669

PAW37

NOMESCO Finland

Biopsy of temporal artery

7.2

214.0

317

442

H05AA02

ATC

teriparatide; parenteral

9.1

213.8

262

291

NK4AT

NOMESCO Finland

Puncture of joint with ultrasound guidance not elsewher classified

5.7

213.7

397

698

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.2

213.3

863

2732

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.3

211.5

811

2485

NCF10

NOMESCO Finland

Synovectomy of elbow joint, open

30.8

211.3

138

NHM20

NOMESCO Finland

Excision of synovial ganglion of ankle or foot

5.0

211.1

463

945

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

5.0

210.6

454

913

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

209.5

8447

61350

ZXE00

NOMESCO Finland

One hour or less

1.5

209.5

11108

85257

NJ3DA

NOMESCO Finland

Long bones of extremities X-ray examination

10.3

208.8

233

228

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.6

208.1

699

1967

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.7

207.9

1172

4457

JF1BD

NOMESCO Finland

Very extensive small bowel CT

7.6

207.9

294

389

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

7.0

207.6

315

451

M81.4

ICD-10 Finland

Drug-induced osteoporosis

9.6

207.3

244

257

L34

ICPC

Musculoskeletal, Blood test

46.7

206.7

121

M33.2

ICD-10 Finland

Polymyositis

20.1

206.5

158

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

15.8

205.1

176

112

M17.5

ICD-10 Finland

Other secondary gonarthrosis

4.3

204.8

543

1291

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

5.9

204.7

371

637

NF2AT

NOMESCO Finland

Injection to hip joint with ultrasound guidance

7.4

202.4

294

401

L04AD02

ATC

tacrolimus; systemic

4.7

202.2

469

1003

A02BC01

ATC

omeprazole; systemic

1.5

202.2

7513

53555

P01BA01

ATC

chloroquine; systemic

8.9

200.7

249

281

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.7

198.4

1075

4005

M01CC01

ATC

penicillamine; oral

22.4

198.4

145

H22.1*M45

ICD-10 Finland

Iridocyclitis in ankylosing spondylitis

19.3

197.9

154

E000003, ,

ATC

2.4

197.9

1408

5984

6960A

ICD-9 Finland

Psoriasis and similar disorders, Psoriatic arthropathy

19.0

197.6

155

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

197.1

9912

75068

L99

ICPC

Musculoskeletal disease other

3.3

196.5

750

2291

P01AB01

ATC

metronidazole; oral, rectal

1.4

196.0

11613

90708

NDG74

NOMESCO Finland

Fusion of first IP joint

12.6

194.4

190

152

L01AA01

ATC

cyclophosphamide; systemic

11.0

193.7

206

188

M08.8

ICD-10 Finland

Other juvenile arthritis

66.4

193.5

106

TNF11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in hip joint

17.2

193.3

159

XPX04

NOMESCO Finland

Angioscopy

8.4

193.3

251

300

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.1

193.3

1948

9559

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.6

193.2

1136

4411

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

192.8

2951

16715

RK210, ,

NOMESCO Finland

13.4

192.3

181

136

ZX112

NOMESCO Finland

Subcutaneous

3.3

191.8

739

2270

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

12.5

191.1

187

150

E000002, ,

ATC

1.8

188.9

3289

19361

M01AH02

ATC

rofecoxib; oral

1.8

188.4

3425

20415

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

187.8

11424

89457

N03AX16

ATC

[U] pregabalin

1.5

187.7

6508

45581

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

4.7

186.1

439

952

J99.1*M31.3

ICD-10 Finland

Respiratory disorders in Wegener's granulomatosis

31.1

185.9

121

ZXX09

NOMESCO Finland

Extent of procedure, more than 8 units

20.1

185.6

142

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.9

185.6

2599

14305

RS221, ,

NOMESCO Finland

3.9

185.5

560

1464

NDF68

NOMESCO Finland

Operation for osteochondritis of several joints of hand, open

47.1

184.8

108

393

Kela drug reimbursment

Pomalidomide

608.3

183.8

182

D64.9

ICD-10 Finland

Anaemia, unspecified

1.9

183.8

2644

14677

L01AA03

ATC

melphalan; systemic

26.7

182.6

125

M01AE02

ATC

naproxen; oral, rectal

1.4

182.5

16690

140157

A07EC03

ATC

olsalazine; oral

14.6

182.2

163

112

L04AF02

ATC

baricitinib; oral

87.5

182.2

L04AX06

ATC

pomalidomide; oral

601.5

181.7

180

XQ848

NOMESCO Finland

Dermatological photography

2.8

181.4

932

3376

GD1AD

NOMESCO Finland

Thorax CT examination

2.2

180.6

1644

7749

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.4

180.4

1275

5399

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

180.3

5268

35462

M07.5

ICD-10 Finland

Arthropathy in ulcerative colitis

51.6

179.7

103

WX2DD

NOMESCO Finland

Low-dose CT of skeleton in whole body

14.4

178.8

161

112

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.9

178.1

843

2921

K71

ICPC

Rheumatic fever/heart disease

49.2

177.9

103

C03CA01

ATC

furosemide; systemic

1.5

177.4

6672

47468

M05.0

ICD-10 Finland

Felty syndrome

27.4

176.8

120

NCB20

NOMESCO Finland

Primary total prosthetic replacement of elbow joint

19.8

176.6

136

ZXX04

NOMESCO Finland

Extent of procedure, 4 units

7.8

176.1

245

318

3AC01, ,

NOMESCO Finland

4.8

174.3

401

852

A02BC05

ATC

esomeprazole; systemic

1.4

173.4

11454

90651

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.0

173.1

1980

10166

1507

Kela drug reimbursment

Pomalidomide

571.1

172.4

171

J01CA04

ATC

amoxicillin; systemic

1.5

172.4

24746

224070

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

18.9

170.7

134

M08.1

ICD-10 Finland

Juvenile ankylosing spondylitis

42.6

170.6

102

5552A

ICD-9 Finland

Regional enteritis, Small intestine with large intestine

33.8

170.1

108

7143D

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[OLIGARTHRITIS JUVENILIS]

24.9

169.5

119

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

168.3

6407

45625

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

167.5

10420

81467

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

3.9

167.4

494

1271

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

167.1

6376

45412

RT171, ,

NOMESCO Finland

16.9

166.4

138

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

5.4

165.2

329

617

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

3.6

164.5

551

1547

L04AX02

ATC

thalidomide; oral

60.8

163.6

M19.2

ICD-10 Finland

Other secondary arthrosis

3.9

163.4

490

1275

SPAT1202

SPAT

Intra-articular injection

2.7

163.4

923

3510

4AC07, ,

NOMESCO Finland

79.3

162.9

108

Kela drug reimbursment

Myasthenia gravis

10.6

162.9

178

169

SPAT1153

SPAT

Removal of sutures

1.4

162.6

8415

63565

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

161.1

3136

19005

7200A

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis

10.0

160.8

183

184

TQW40

NOMESCO Finland

Remowal of suture of skin

1.9

158.4

2048

10958

M05BA06

ATC

ibandronic acid; systemic

3.4

158.3

591

1780

G70.0

ICD-10 Finland

Myasthenia gravis

8.5

158.1

204

242

A05AA02

ATC

ursodeoxycholic acid; oral

3.3

157.9

605

1852

NHG22

NOMESCO Finland

Fusion of subtalar joint

5.6

157.6

298

533

JFA38

NOMESCO Finland

Endoscopic dilatation of small intestine

30.4

157.0

103

ZX108

NOMESCO Finland

Inhalation

5.4

156.7

312

585

D05AA

ATC

Tars

6.4

156.5

261

413

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.9

156.4

770

2725

ZZH31

NOMESCO Finland

Bone allograft, small pieces

5.2

154.5

319

618

ZXA00

NOMESCO Finland

Right side

1.5

154.3

6813

49848

JF1AD

NOMESCO Finland

Small bowel CT

5.8

153.5

283

494

R1250

NOMESCO Finland

Evaluation of functional capability

2.9

153.2

732

2548

9527

FHL

Alloarthroplasty, implant or endoprosthesis

36.6

152.9

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

8.7

152.7

193

223

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.7

152.5

2832

16926

M07.4

ICD-10 Finland

Arthropathy in Crohn disease [regional enteritis]

45.1

152.5

B07.9

ICD-10 Finland

Verruca simplex

2.3

152.2

1158

5061

WX320

NOMESCO Finland

Spinalanesthesy

1.5

151.6

6392

46323

RJ421, ,

NOMESCO Finland

8.2

151.3

201

247

L03AB07

ATC

interferon beta-1a; parenteral

5.7

151.2

280

491

9835/3-C42.1

ICD-O-3

Precursor cell lymphoblastic leukemia, NOS, of bone marrow

21.6

151.0

112

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

3.7

150.9

486

1329

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.9

149.2

2080

11400

M05BB03

ATC

alendronic acid and colecalciferol; oral

3.1

148.6

622

2008

D02AX

ATC

Other emollients and protectives

2.5

148.2

1000

4142

NA6CG

NOMESCO Finland

Sacro-iliac joint extensive MRI examination with high intensity magnet

6.8

148.1

233

347

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

3.3

147.4

578

1794

S97

ICPC

Chronic ulcer skin

2.1

146.7

1544

7682

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

6.7

146.0

231

346

5BA08, ,

NOMESCO Finland

6.7

146.0

230

343

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

146.0

4112

27316

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.2

145.5

1363

6487

A02BA02

ATC

ranitidine; systemic

1.5

145.4

4815

33161

RJ411, ,

NOMESCO Finland

6.3

144.9

245

393

L40.4

ICD-10 Finland

Guttate psoriasis

6.6

143.2

230

350

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

143.2

2431

14149

L03AX13

ATC

glatiramer acetate; parenteral

6.5

143.0

233

360

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.0

143.0

1673

8644

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.9

142.8

1987

10881

M01AB55

ATC

diclofenac, combinations; oral

2.0

142.7

1736

9091

M31.1

ICD-10 Finland

Thrombotic microangiopathy

21.9

142.4

105

S01BA04

ATC

prednisolone; ophthalmic

3.0

142.2

637

2139

Z2446

NOMESCO Finland

Social worker

1.9

142.1

1850

9911

JFH11

NOMESCO Finland

Laparoscopic colectomy

29.4

141.9

NDC40

NOMESCO Finland

Secondary prosthetic replacement in of joint of finger or metacarpal

36.7

141.7

L04AC21

ATC

bimekizumab; systemic

76.1

141.4

B02.9

ICD-10 Finland

Zoster without complication

2.0

141.3

1740

9150

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

140.3

3605

23414

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

140.1

10228

81510

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.0

139.7

648

2219

4AA24, ,

NOMESCO Finland

64.3

139.6

S01BA01

ATC

dexamethasone; ophthalmic

2.4

139.4

1019

4374

L95

ICPC

Osteoporosis

2.4

139.2

990

4199

NF1DA

NOMESCO Finland

X-ray of hips

3.0

137.9

643

2208

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

3.5

137.9

477

1368

N02AA05

ATC

oxycodone; systemic

1.6

137.6

4143

27910

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.4

137.4

970

4100

N03AX12

ATC

[U] gabapentin; oral

1.5

136.4

4386

29975

TAB00

NOMESCO Finland

Lumbar puncture

2.1

136.2

1323

6383

WX204

NOMESCO Finland

Axillary plexus blockaced

2.4

135.7

965

4092

M02.8

ICD-10 Finland

Other reactive arthropathies

6.3

133.3

223

354

H46

ICD-10 Finland

Optic neuritis

4.4

132.8

339

783

A46

ICD-10 Finland

Erysipelas

1.6

132.2

3601

23693

137

Kela drug reimbursment

Uraemia requiring dialysis

4.5

132.1

322

717

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.9

131.4

620

2143

I41.8*D86.8

ICD-10 Finland

Sarcoid myocarditis

8.8

130.3

163

186

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.1

130.3

1300

6336

ND2AE

NOMESCO Finland

Hand and fingers ultrasound examination

11.2

130.2

137

123

69619

ICD-8 Finland

Psoriasis and similar disorders, Psoriasis alia sive NUD (vulgaris)

8.2

130.2

172

210

Z94.4

ICD-10 Finland

Liver transplant status

7.3

130.0

190

261

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.9

129.1

1775

9674

NHG82

NOMESCO Finland

Fusion of other tarsal joint

4.1

129.0

359

885

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

128.8

3309

21461

L88

ICD-10 Finland

Pyoderma gangrenosum

10.3

128.8

143

139

5550A

ICD-9 Finland

Regional enteritis, Small intestine

25.1

128.5

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

128.3

5696

41507

WVA20

NOMESCO Finland

Medicine administration

2.6

127.8

771

3027

M33.1

ICD-10 Finland

Other dermatomyositis

20.3

127.3

1XX32, ,

NOMESCO Finland

40.6

127.2

9272

FHL

Metatarsophalangeal joint resection

9.3

126.9

152

164

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

13.1

126.0

120

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

125.8

3194

20652

M46.8

ICD-10 Finland

Other specified inflammatory spondylopathies

12.6

125.3

122

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

125.0

14405

122334

J01MA14

ATC

moxifloxacin; systemic

1.7

124.3

2327

13902

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

124.2

10819

88176

M01AX01

ATC

nabumetone; oral

2.2

123.9

1152

5462

SPAT1255

SPAT

Intravenous administration of medicine

1.9

123.7

1768

9752

M06.1

ICD-10 Finland

Adult-onset Still disease

21.4

123.6

M43.4

ICD-10 Finland

Other recurrent atlantoaxial subluxation

18.0

123.3

M31.9

ICD-10 Finland

Necrotizing vasculopathy, unspecified

12.0

123.2

124

104

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

3.8

122.4

371

973

L28

ICPC

Limited function/disability (L)

1.5

121.6

4165

28789

EG1CG

NOMESCO Finland

Extensive MRI examination of mandibular joint with high intensity magnet

8.1

121.5

162

200

M33.9

ICD-10 Finland

Dermatopolymyositis, unspecified

15.8

121.3

104

ZXA05

NOMESCO Finland

Left side

1.4

120.7

6168

46056

C08CA05

ATC

nifedipine; systemic

2.0

120.4

1465

7663

G37.9

ICD-10 Finland

Demyelinating disease of central nervous system, unspecified

4.5

120.4

291

644

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

120.2

1137

5427

7148X

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Other specified inflammatory polyarthropathies

14.0

120.0

110

M16.7

ICD-10 Finland

Other secondary coxarthrosis

4.4

119.7

298

675

L12.0

ICD-10 Finland

Bullous pemphigoid

6.0

119.7

211

353

N86

ICPC

Multiple sclerosis

4.9

119.2

263

540

NDG76

NOMESCO Finland

Fusion of DIP joint

4.3

119.1

310

727

M01AX17

ATC

nimesulide; oral

1.4

119.0

6015

44809

M79.6

ICD-10 Finland

Pain in limb

1.3

118.9

11529

95280

WX203

NOMESCO Finland

Infraclavicular plexus blockade

2.5

118.2

737

2940

M05BA01

ATC

etidronic acid; systemic

6.3

118.1

198

315

ZY010

NOMESCO Finland

Hospital outpatient

1.9

117.7

1479

7820

2AB04, ,

NOMESCO Finland

9.2

117.2

141

153

NG2CA

NOMESCO Finland

X-ray of patella with specialised projection

5.6

117.0

223

402

RJ410, ,

NOMESCO Finland

6.8

117.0

183

271

M17.4

ICD-10 Finland

Other secondary gonarthrosis, bilateral

5.9

116.2

207

350

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

116.1

4919

35447

A12AA04

ATC

calcium carbonate; oral

3.2

116.1

463

1452

7143B

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[POLYARTHRITIS JUVENILIS SEROPOSITIVA]

34.8

115.8

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.6

115.5

2589

16214

N07AA02

ATC

pyridostigmine; systemic

5.8

115.2

210

363

YNB10

NOMESCO Finland

Collection of stem cells for transplant

12.8

115.0

111

5551A

ICD-9 Finland

Regional enteritis, Large intestine

28.6

115.0

M31.7

ICD-10 Finland

Microscopic polyangiitis

18.2

113.9

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

113.5

3690

25196

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.9

113.2

553

1948

L17

ICPC

Foot/toe symptom/complaint

1.4

113.1

7657

59829

R06.0

ICD-10 Finland

Dyspnoea

1.4

113.0

6727

51476

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

3.5

112.5

392

1130

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.9

112.2

1571

8604

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

111.8

6841

52573

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.6

111.7

2601

16437

E000007, ,

ATC

1.9

111.7

1520

8248

JFB20

NOMESCO Finland

Ileocaecal resection

5.7

111.5

209

371

M04AA01

ATC

allopurinol; systemic

1.6

111.5

2790

17947

J01FA06

ATC

roxithromycin; oral

1.3

111.3

10672

87810

SPAT1325

SPAT

Vaccination

1.4

111.3

8464

67309

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

111.1

2828

18263

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

2.3

110.1

823

3565

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.9

110.0

1460

7858

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

5.3

109.8

223

426

ZXX08

NOMESCO Finland

Extent of procedure, 8 units

16.9

109.8

N08.5

ICD-10 Finland

Glomerular disorders in systemic connective tissue disorders

24.9

109.6

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.1

109.5

463

1504

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.8

109.2

1806

10404

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.9

109.0

321

825

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.9

108.7

1418

7587

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

8.8

108.0

135

154

R2110

NOMESCO Finland

Giving the first information

1.8

107.7

1866

10894

J01AA02

ATC

doxycycline; systemic

1.3

107.6

22066

200969

J99.0*M05.1

ICD-10 Finland

Rheumatoid lung disease

32.9

107.6

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

107.6

6463

49465

ZXD05

NOMESCO Finland

Urgent procedure

1.4

107.4

7914

62566

Z85.6

ICD-10 Finland

Personal history of leukaemia

29.6

107.3

SPAT1229

SPAT

Assessment of need for aid

1.8

107.1

1822

10580

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

106.6

19632

176015

XG410

NOMESCO Finland

Flow-volume spirometry

2.1

106.5

1039

5016

E000006, ,

ATC

1.8

106.4

1802

10451

RJ511, ,

NOMESCO Finland

9.6

106.4

124

129

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.5

105.5

3464

23674

A07AA09

ATC

vancomycin; oral

3.2

105.5

418

1306

ND2CG

NOMESCO Finland

Extensive MRI of hand

7.5

105.4

151

203

6112

FHL

Installation of a peritoneal dialysis or lavage catheter in an operating room

59.1

105.3

K83.0

ICD-10 Finland

Cholangitis

3.2

105.3

422

1328

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

103.7

11026

91785

ZXX06

NOMESCO Finland

Extent of procedure, 6 units

9.8

103.2

119

122

M08.2

ICD-10 Finland

Juvenile arthritis with systemic onset

24.4

103.1

6961A

ICD-9 Finland

Psoriasis and similar disorders, Other psoriasis[PSORIASIS VULGARIS]

8.6

102.5

130

151

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.1

102.0

1053

5192

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.5

102.0

665

2709

RS222, ,

NOMESCO Finland

3.4

102.0

375

1119

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

101.9

20740

187812

5562A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) proctitis

8.8

101.5

127

145

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

101.3

6386

49188

H30.2

ICD-10 Finland

Posterior cyclitis

7.2

101.0

149

207

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

5.2

100.9

207

399

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

3.0

100.9

457

1544

D05AX05

ATC

tazarotene; topical

11.2

100.9

106

M34.0

ICD-10 Finland

Progressive systemic sclerosis

14.5

100.4

TNB10

NOMESCO Finland

Joint puncture, shoulder joint

8.8

100.3

125

142

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

100.2

14833

128753

K07.60

ICD-10 Finland

Snapping jaw

1.8

100.1

1464

8123

ZXA10

NOMESCO Finland

Bilateral

1.4

99.9

4579

33388

A11CC03

ATC

alfacalcidol; systemic

2.5

99.8

634

2551

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

5.2

99.7

205

396

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

99.4

6849

53476

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

99.3

3870

27363

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

3.6

99.1

335

947

RD210, ,

NOMESCO Finland

2.7

99.0

558

2118

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

98.7

1899

11408

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.4

98.5

706

3003

SPAT1263

SPAT

Sampling

1.3

98.1

11319

95048

RS121, ,

NOMESCO Finland

4.6

98.0

236

521

J01DA01

ATC

[U] cefalexin

1.3

97.9

17165

152023

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.5

97.9

628

2539

Z71.8

ICD-10 Finland

Other specified counselling

1.3

97.4

8410

67858

JFH33

NOMESCO Finland

Total colectomy, mucosal proctectomy, ileoanal anastomosis and ileostomy

16.0

97.4

JFH20

NOMESCO Finland

Proctocolectomy and ileostomy

16.0

97.4

9311

FHL

Knee cleansing surgery (synovectomy, debridement)

10.0

96.2

109

M79.7

ICD-10 Finland

Fibromyalgia

2.1

96.2

999

4936

JN3AD

NOMESCO Finland

Abdominal CT examination

1.5

96.1

2848

19014

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

96.1

1437

8025

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

96.0

8087

64995

132

Kela drug reimbursment

Sarcoidosis

4.6

95.9

230

506

RJ512, ,

NOMESCO Finland

10.5

95.9

105

100

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.2

95.6

812

3712

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.9

95.4

1292

6994

N08.5*M31.7

ICD-10 Finland

Glomerular disease states in microscopic polyangiitis

20.6

95.1

N02BA01

ATC

acetylsalicylic acid; systemic, rectal

15.9

94.8

RF410, ,

NOMESCO Finland

3.2

94.6

372

1157

9289

FHL

Other measure in this category

14.4

94.4

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.8

94.4

1609

9341

NC1AE

NOMESCO Finland

Elbow ultrasound examination

9.9

93.8

107

108

M35.8

ICD-10 Finland

Other specified systemic involvement of connective tissue

9.9

93.8

107

108

R03AC02

ATC

salbutamol; inhalant

1.3

93.5

15399

134975

N08.5*M32.1

ICD-10 Finland

Glomerular disorders in systemic lupus erythematosus

16.2

93.2

WXQ12

NOMESCO Finland

Psoralen - Ultraviolet A therapy with local sensitivisation

5.7

93.2

174

308

M66.0

ICD-10 Finland

Rupture of popliteal cyst

3.0

92.9

409

1360

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.2

92.9

811

3748

J01FA10

ATC

azithromycin; systemic

1.3

92.8

16584

146760

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

6.0

92.8

163

272

RT350, ,

NOMESCO Finland

10.9

92.7

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.9

92.4

1216

6520

M25.4

ICD-10 Finland

Effusion of joint

3.0

92.1

416

1404

NHB10

NOMESCO Finland

Primary partial prosthetic replacement of ankle joint

9.4

91.9

109

116

TEG10

NOMESCO Finland

Injection of diagnostic or therapeutic substance into mandibular joint

10.4

91.7

101

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.7

91.6

1625

9540

L11

ICPC

Wrist symptom/complaint

1.6

91.2

2364

15300

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.1

90.5

849

4036

R60.0

ICD-10 Finland

Localized oedema

1.5

90.4

2918

19832

R06AE07

ATC

cetirizine; oral

1.3

90.3

12291

105064

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.6

90.0

520

1999

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

89.9

7914

63881

5561A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) ileocolitis

7.5

89.9

128

171

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

2.4

89.9

653

2794

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

5.9

89.8

161

274

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

3.1

89.7

382

1246

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.7

89.4

1887

11608

NDL66

NOMESCO Finland

Transposition of tendon of wrist or hand, other tendon

5.8

89.4

163

282

398

Kela drug reimbursment

Ixazomib

443.9

89.2

S01CA02

ATC

prednisolone and antiinfectives; ophthalmic

3.3

88.8

336

1021

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

88.7

1586

9331

9283

FHL

Subtalar joint ossification surgery (or triple)

12.7

88.6

Z01.2

ICD-10 Finland

Dental examination

1.3

88.6

12863

110734

7100A

ICD-9 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

12.9

88.5

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

3.4

88.5

315

921

M49.5*C90.0

ICD-10 Finland

Vertebral fracture due to multiple myeloma

51.1

88.4

RT231, ,

NOMESCO Finland

21.3

88.4

5568X

ICD-9 Finland

Idiopathic proctocolitis, Other ulcerative colitis

8.1

87.9

118

147

ZXX05

NOMESCO Finland

Extent of procedure, 5 units

6.0

87.9

156

263

NHG20

NOMESCO Finland

Fusion of talocrural joint

4.4

87.7

222

510

TQW99

NOMESCO Finland

Other minor procedure on skin

1.9

87.5

1195

6485

A07AA02

ATC

nystatin; oral

1.8

87.2

1422

8147

B03XA02

ATC

darbepoetin alfa; parenteral

2.6

87.1

516

2008

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

2.4

86.9

602

2521

R5120

NOMESCO Finland

Preparation of an aid

2.3

86.9

663

2898

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.6

86.6

2126

13579

D06BB04

ATC

podophyllotoxin; topical

1.8

86.4

1369

7776

RJ420, ,

NOMESCO Finland

5.6

86.0

162

289

56300

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Regional enteritis

10.2

86.0

M32

ICD-10 Finland

Systemic lupus erythematosus

11.6

85.8

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.8

85.8

448

1636

QC6S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in hand

8.0

85.7

116

146

NHF80

NOMESCO Finland

Operation for debridement of toe joint, open

12.2

85.4

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

84.9

3219

22588

R3130

NOMESCO Finland

Training in activities of daily lining

25.7

84.9

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

84.8

2976

20564

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

2.5

84.7

557

2278

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

84.7

6487

51263

N04.80

ICD-10 Finland

Congenital nephrotic syndrome of the Finnish type

45.5

84.6

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.4

84.5

3566

25540

1505

Kela drug reimbursment

Ixazomib

418.7

84.0

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

3.7

83.9

269

734

RF120, ,

NOMESCO Finland

3.2

83.9

345

1103

J02AC01

ATC

fluconazole; systemic

1.3

83.6

10863

92054

E85.3

ICD-10 Finland

Secondary systemic amyloidosis

21.4

83.2

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

4.7

83.1

193

414

NDG77

NOMESCO Finland

Other excision, reconstruction or fusion of joint of first finger

6.7

83.0

131

196

I77.6

ICD-10 Finland

Arteritis, unspecified

7.9

82.6

113

144

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

82.3

7147

57455

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

82.0

5580

43296

K73.0

ICD-10 Finland

Chronic persistent hepatitis, not elsewhere classified

15.9

82.0

M35.7

ICD-10 Finland

Hypermobility syndrome

2.7

81.7

431

1582

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

2.6

81.2

494

1948

JF1DM

NOMESCO Finland

Very extensive MRI of small bowel (more than 1.5 T)

22.7

81.0

XQ841

NOMESCO Finland

Examination of dermatosis with microscope

8.2

80.9

107

131

RF420, ,

NOMESCO Finland

2.8

80.8

397

1404

QDH05

NOMESCO Finland

Correction of deformity of toe nail

5.9

80.7

144

244

H40.4

ICD-10 Finland

Glaucoma secondary to eye inflammation

9.1

80.5

108

N05.8

ICD-10 Finland

Unspecified nephritic syndrome, other

19.1

80.5

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

4.0

80.4

229

575

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

1.9

80.4

1032

5486

S01FA04

ATC

cyclopentolate; ophthalmic

3.3

80.2

311

960

1370

FHL

Colonoscopy, whole colon

5.1

80.1

167

327

NH1EA

NOMESCO Finland

Ankle X-ray examination with load or wrench

5.1

80.0

168

331

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.8

79.8

1357

7866

5AB14, ,

NOMESCO Finland

8.2

79.7

105

128

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

3.3

79.6

296

890

L12

ICPC

Hand/finger symptom/complaint

1.4

79.5

4192

31208

EG1DG

NOMESCO Finland

Very extensive MRI examination of mandibular joint with high intensity magnet

12.2

79.4

K02.1

ICD-10 Finland

Caries of dentine

1.3

79.3

16813

150484

K60.3

ICD-10 Finland

Anal fistula

2.5

79.2

486

1924

Z22.30

ICD-10 Finland

Latent tuberculosis

17.8

79.1

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

79.0

9860

82986

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

6.0

78.9

140

236

M05.2

ICD-10 Finland

Rheumatoid vasculitis

21.1

78.7

602

Kela drug reimbursment

Children's severe malnutrition

6.2

78.6

133

214

9260

FHL

Alloarthroplasty, endoprosthesis or implant

22.8

78.4

NDU20

NOMESCO Finland

Removal of internal fixation device from wrist or hand

2.4

78.1

567

2425

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

2.2

78.0

638

2871

WW409

NOMESCO Finland

Other aferesis

6.8

77.9

122

181

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

5.6

77.6

147

264

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

77.5

2934

20561

L84

ICD-10 Finland

Corns and callosities

2.0

77.2

872

4438

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.1

77.2

790

3881

H15.1

ICD-10 Finland

Episcleritis

2.6

77.1

436

1659

NHM99

NOMESCO Finland

Other operation on fascia, ganglion, synovial sheath or bursa of ankle or foot

4.1

77.0

214

528

TK800

NOMESCO Finland

Hemodialysis

2.4

77.0

543

2293

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

3.6

76.6

249

686

JX1LA

NOMESCO Finland

Kinetic X-ray of alimentary tract with pictures

8.1

76.6

102

126

AA1AA

NOMESCO Finland

Head X-ray examination

3.7

76.4

240

646

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.1

76.4

729

3489

9531

FHL

Arthrodesis of the hand joint

5.8

76.1

139

241

L01XE31

ATC

[U] nintedanib

10.0

75.9

Z94.1

ICD-10 Finland

Heart transplant status

7.0

75.8

115

165

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

3.2

75.8

305

963

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.9

75.3

964

5120

ND1CG

NOMESCO Finland

Wrist and hand extensive MRI examination with high intensity magnet

3.3

75.3

282

852

RJ412, ,

NOMESCO Finland

7.9

75.1

102

129

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

3.7

75.1

238

645

JF1CM

NOMESCO Finland

Small bowel extensive MRI with with high intensity magnet

17.5

74.7

ZX100

NOMESCO Finland

Oral

2.8

74.6

371

1321

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

4.0

74.5

214

541

D09AB01

ATC

zinc bandage without supplements; topical

2.4

74.4

501

2072

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

1.8

74.2

1253

7246

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.2

74.2

623

2834

5559X

ICD-9 Finland

Regional enteritis, Unspecified site

32.0

74.1

L93.0

ICD-10 Finland

Discoid lupus erythematosus

4.4

74.0

183

413

JGB50

NOMESCO Finland

Mucosal proctectomy and ileoanal anastomosis

13.9

74.0

A41.9

ICD-10 Finland

Sepsis, unspecified

2.0

73.7

791

3954

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

73.6

1642

10232

ACC51

NOMESCO Finland

Release of median nerve

1.6

73.6

1887

12162

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.7

73.4

3061

41996

395

Kela drug reimbursment

Dupilumab

7.3

73.3

107

147

WW400

NOMESCO Finland

Plasmaferesis

7.7

73.2

102

133

M31.6

ICD-10 Finland

Other giant cell arteritis

6.5

73.1

119

184

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.9

72.5

1025

5619

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.5

72.4

2186

14616

H15.0

ICD-10 Finland

Scleritis

5.1

72.3

152

300

L26

ICD-10 Finland

Exfoliative dermatitis

7.3

72.1

105

144

Z93.2

ICD-10 Finland

Ileostomy status

5.2

72.1

148

286

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.2

71.9

610

2787

M71.2

ICD-10 Finland

Synovial cyst of popliteal space [Baker]

1.9

71.9

863

4486

6BA02, ,

NOMESCO Finland

5.6

71.6

134

238

SBA10

NOMESCO Finland

Measurement of salivary flow rate

3.1

71.6

303

986

R05

ICD-10 Finland

Cough

1.3

71.5

5419

42609

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

4.5

71.5

173

384

NHL50

NOMESCO Finland

Tenolysis or tenosynovectomy of foot

4.6

71.3

169

369

RJ190, ,

NOMESCO Finland

7.0

71.2

108

155

M02AA07

ATC

piroxicam; topical

1.3

71.1

8841

74145

B05DA

ATC

Isotonic solutions

3.7

70.9

225

610

L03AB08

ATC

interferon beta-1b; parenteral

6.0

70.7

125

210

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.2

70.5

632

2951

RT172, ,

NOMESCO Finland

9.7

70.5

JN4AD

NOMESCO Finland

Body CT examination

1.5

70.3

2314

15752

M09.2*K51.9

ICD-10 Finland

Juvenile arthritis in ulcerative colitis

30.7

70.1

M60.9

ICD-10 Finland

Myositis, unspecified

4.1

70.0

190

461

RT160, ,

NOMESCO Finland

8.8

69.8

SFA10

NOMESCO Finland

One-surface restoration

1.2

69.5

15379

137388

TEG00

NOMESCO Finland

Punction of mandibular joint

9.0

69.1

D07AA02

ATC

hydrocortisone; topical

1.4

68.7

3527

26085

M94.1

ICD-10 Finland

Relapsing polychondritis

17.5

68.7

B03BA03

ATC

hydroxocobalamin; parenteral

1.8

68.7

1173

6805

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

3.3

68.7

266

821

NK6PA

NOMESCO Finland

Measurement of bone density from one location with X-ray

5.5

68.6

133

244

A01

ICPC

Pain general/multiple sites

1.5

68.5

2186

14782

Z50.1

ICD-10 Finland

Other physical therapy

1.7

68.1

1258

7459

A28

ICPC

Limited function/disability NOS

1.4

68.1

3383

24883

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.7

68.0

1334

8039

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

1.8

67.9

1048

5901

NHK40

NOMESCO Finland

Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone

2.4

67.8

475

2000

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

67.7

9226

78105

R11

ICD-10 Finland

Nausea and vomiting

1.5

67.3

2078

13954

RT274, ,

NOMESCO Finland

7.4

67.1

132

A02BB01

ATC

misoprostol; oral

4.3

66.9

175

413

M06.2

ICD-10 Finland

Rheumatoid bursitis

24.8

66.6

ND2BG

NOMESCO Finland

MRI of hand

6.3

66.6

111

176

R4190

NOMESCO Finland

Nutritional therapy

1.8

66.6

996

5557

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

66.2

4144

31633

Z94.2

ICD-10 Finland

Lung transplant status

7.2

66.2

137

D11AH04

ATC

alitretinoin; oral

9.6

66.1

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

66.0

20796

192317

SPAT1301

SPAT

No procedures

1.3

66.0

7826

65135

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

65.9

4093

31206

EG1AA

NOMESCO Finland

Mandibular joint X-ray examination

4.5

65.7

160

357

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

65.6

5162

40740

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

2.9

65.5

302

1032

JHA00

NOMESCO Finland

Anal or perianal incision

2.6

65.5

384

1488

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.7

65.5

1357

8296

56310

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Ulcerative colitis

4.8

65.4

148

311

D11AH05

ATC

dupilumab; topical

6.5

65.1

106

164

K76.9

ICD-10 Finland

Liver disease, unspecified

2.6

64.8

372

1426

NCM20

NOMESCO Finland

Excision of synovial ganglion of elbow or forearm

5.2

64.8

133

257

C90.2

ICD-10 Finland

Extramedullary plasmacytoma

12.6

64.7

H26.2

ICD-10 Finland

Complicated cataract

2.7

64.7

344

1269

71240

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Spondylitis ankylopoietica

6.5

64.7

105

162

M34.8

ICD-10 Finland

Other forms of systemic sclerosis

14.5

64.6

UJF02

NOMESCO Finland

Peroral enteroscopy

3.8

64.5

194

507

M01AB01

ATC

indometacin; systemic, rectal

1.6

64.1

1507

9507

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

2.7

63.9

357

1351

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

63.8

4801

37642

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.9

63.7

840

4503

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

2.2

63.7

544

2492

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

63.7

1316

8037

JFB21

NOMESCO Finland

Laparoscopic ileocaecal resection

7.4

63.7

125

WW500

NOMESCO Finland

Blood transfusion

1.8

63.6

927

5129

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.4

63.6

2678

19113

M65.9

ICD-10 Finland

Synovitis and tenosynovitis, unspecified

2.0

63.4

689

3459

TFJ02

NOMESCO Finland

Muscle biopsy of heart

6.6

63.4

102

156

0108, ,

NOMESCO Finland

25.9

63.4

L04AA05

ATC

[U] tacrolimus

10.2

63.3

L40.1

ICD-10 Finland

Generalized pustular psoriasis

12.4

63.1

A03

ICPC

Fever

1.3

63.0

4432

34406

WZA00

NOMESCO Finland

Concise certificate

1.6

62.8

1606

10337

N02BF02

ATC

pregabalin; oral

1.6

62.7

1439

9023

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

1.7

62.7

1250

7563

S01XA18

ATC

ciclosporin; ophthalmic

3.4

62.6

229

682

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.4

62.3

428

1787

V03AG01

ATC

sodium cellulose phosphate; systemic

9.2

62.0

D11AH01

ATC

tacrolimus; topical

2.9

62.0

295

1026

L01EX09

ATC

nintedanib; oral

6.8

62.0

144

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

62.0

3454

25866

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.0

61.9

677

3407

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.7

61.9

337

1259

J99.1

ICD-10 Finland

Respiratory disorders in other diffuse connective tissue disorders

20.5

61.8

JFB33

NOMESCO Finland

Other resection comprising small intestine and colon

8.1

61.7

101

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

5.0

61.7

131

261

4AA09, ,

NOMESCO Finland

22.5

61.5

RJ210, ,

NOMESCO Finland

6.0

61.3

108

181

NH1AD

NOMESCO Finland

Ankle and foot CT

2.1

61.2

591

2842

J04BA02

ATC

dapsone; oral

3.9

60.9

182

474

SFA20

NOMESCO Finland

Two-surface restoration

1.2

60.9

16427

148847

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

60.8

1627

10581

H57.1

ICD-10 Finland

Ocular pain

1.8

60.6

945

5338

L04AA31

ATC

[U] teriflunomide

5.2

60.4

123

236

M35.2

ICD-10 Finland

Behçet disease

14.6

60.4

69600

ICD-8 Finland

Psoriasis and similar disorders, Psoriatic arthropathy

13.7

60.3

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

60.2

3312

24742

RF212, ,

NOMESCO Finland

5.0

60.1

130

263

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.1

60.0

584

2816

D07BC01

ATC

betamethasone and antiseptics; topical

1.4

59.8

2836

20665

I73.0

ICD-10 Finland

Raynaud syndrome

2.3

59.5

457

2004

M02.3

ICD-10 Finland

Reiter disease

8.0

59.5

100

D05AC01

ATC

dithranol; topical

10.7

59.1

M54.5

ICD-10 Finland

Low back pain

1.2

58.9

9408

80751

NDG71

NOMESCO Finland

Arthrodes of first MP joint

5.3

58.9

119

227

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

58.8

5057

40331

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

1.9

58.7

824

4506

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

5.6

58.4

111

200

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

58.4

6215

50927

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.8

58.3

947

5414

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

6.8

57.8

133

K51.4

ICD-10 Finland

Inflammatory polyps

14.0

57.8

7143X

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[POLYARTHRITIS JUVENILIS NUD]

21.5

57.7

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

3.4

57.6

206

605

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.3

57.5

424

1827

M31.4

ICD-10 Finland

Aortic arch syndrome [Takayasu]

24.1

57.5

M11.2

ICD-10 Finland

Other chondrocalcinosis

5.0

57.4

123

247

L50

ICPC

Musculoskeletal, Medication/prescr/renewal

4.2

57.2

150

355

M30.1

ICD-10 Finland

Polyarteritis with lung involvement [Churg-Strauss]

10.2

57.1

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.7

57.1

1091

6526

M31.8

ICD-10 Finland

Other specified necrotizing vasculopathies

11.4

56.8

NAG42

NOMESCO Finland

Posterior fusion of cervical spine with or without fixation

6.2

56.7

158

C08CA01

ATC

amlodipine; oral

1.2

56.4

8684

74161

N06AA09

ATC

amitriptyline; systemic

1.5

56.4

2186

15347

L16

ICPC

Ankle symptom/complaint

1.4

56.3

2798

20539

M65.8

ICD-10 Finland

Other synovitis and tenosynovitis

2.0

56.3

609

3054

M31.0

ICD-10 Finland

Hypersensitivity angiitis

15.3

56.2

ZX114

NOMESCO Finland

Intramuscular

2.4

56.1

394

1662

M01AB08

ATC

etodolac; oral

1.5

56.1

1692

11293

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

56.0

6634

55012

R5110, ,

SPAT

1.6

56.0

1429

9187

NF1AT

NOMESCO Finland

Puncture of hip joint with ultrasound guidance

4.0

56.0

158

395

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.6

55.9

1448

9344

212

Kela drug reimbursment

Gout

2.4

55.6

378

1572

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.4

55.5

2425

17405

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

4.0

55.5

156

389

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

55.3

658

3411

ZXC50

NOMESCO Finland

Cryotherapy

2.0

55.2

639

3280

NH1DG

NOMESCO Finland

Ankle and foot very extensive MRI examination with high intensity magnet

5.6

55.2

104

186

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

55.2

5189

41826

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.0

55.1

603

3035

JFG73

NOMESCO Finland

Excision of ileal pelvic pouch

18.3

55.1

L57.0

ICD-10 Finland

Actinic keratosis

1.5

55.0

2084

14566

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

3.0

55.0

244

817

L30.3

ICD-10 Finland

Infective dermatitis

1.8

54.9

832

4658

NJ3CG

NOMESCO Finland

Extensive MRI examination of extremities with median high magnet

4.4

54.9

136

308

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

54.9

1936

13345

7165A

ICD-9 Finland

Other and unspecified arthropathies, Unspecified polyarthropathy or polyarthritis

12.6

54.5

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.4

54.5

2305

16445

JJC00

NOMESCO Finland

Allogenic transplantation of liver

5.5

54.4

105

192

K06.18

ICD-10 Finland

Another gingival hyperplasia

4.5

54.4

131

290

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.6

54.1

1237

7747

N02BF01

ATC

gabapentin; oral

1.5

54.1

1925

13292

M48.0

ICD-10 Finland

Spinal stenosis

1.4

54.0

2593

18915

4AB0M, ,

NOMESCO Finland

186.9

53.9

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

8.6

53.7

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

53.6

15258

138194

N06AX21

ATC

duloxetine; oral

1.4

53.6

2896

21547

ZX131

NOMESCO Finland

Intrathecal

15.2

53.6

L15

ICPC

Knee symptom/complaint

1.3

53.6

5894

48415

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.0

53.6

604

3073

J01FA09

ATC

clarithromycin; systemic

1.2

53.5

8142

69359

SAA04

NOMESCO Finland

Special examination of mouth

1.6

53.5

1327

8474

L01XG03

ATC

ixazomib; oral

528.8

53.5

Z99.2

ICD-10 Finland

Dependence on renal dialysis

8.4

53.5

SFA30

NOMESCO Finland

Three-surface restoration

1.2

53.4

11087

97459

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

8.2

53.3

135

Kela drug reimbursment

Pemphigus

21.1

53.2

C07AB07

ATC

bisoprolol; oral

1.2

53.1

11315

99695

A98

ICPC

Health maint/preventive medicine

1.6

53.0

29954

292446

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.8

52.9

771

4266

GDG10

NOMESCO Finland

Bilateral transplantation of lung

7.6

52.9

N18.8

ICD-10 Finland

Other chronic renal failure

2.1

52.8

504

2413

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.7

52.7

942

5533

M43.3

ICD-10 Finland

Recurrent atlantoaxial subluxation with myelopathy

13.6

52.7

M16.6

ICD-10 Finland

Other secondary coxarthrosis, bilateral

5.4

52.6

103

191

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.5

52.6

332

1334

B01AB04

ATC

dalteparin; parenteral

1.6

52.6

1177

7332

L28.1

ICD-10 Finland

Prurigo nodularis

3.2

52.5

205

637

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.9

52.3

719

3907

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

2.6

52.2

307

1192

D07CC01

ATC

betamethasone and antibiotics; topical

1.4

52.2

2947

22075

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.5

52.1

1719

11689

R05

ICPC

Cough

1.3

52.0

6027

49790

M02.1

ICD-10 Finland

Postdysenteric arthropathy

5.0

51.9

110

219

M03BX02

ATC

tizanidine; oral

1.2

51.7

17307

158855

NHF15

NOMESCO Finland

Synovectomy of ankle, arthroscopic

6.0

51.5

153

B05DB

ATC

Hypertonic solutions

3.3

51.5

191

575

TNH33

NOMESCO Finland

Custom moulded brace, ankle or foot

2.3

51.4

399

1758

J45.9

ICD-10 Finland

Asthma, unspecified

1.3

51.4

4521

36093

JFH10

NOMESCO Finland

Total colectomy and ileostomy

5.4

51.4

101

188

WW402

NOMESCO Finland

Leucoferesis

7.9

51.3

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

4.8

51.3

116

244

WX202

NOMESCO Finland

Supraclavicular plexus blockade

2.3

51.3

375

1611

RK250, ,

NOMESCO Finland

3.9

51.1

148

377

XQ802

NOMESCO Finland

Epicutan test

1.7

51.0

999

6013

B02

ICD-10 Finland

Zoster [herpes zoster]

1.7

50.8

954

5680

9294

FHL

Endoprosthesis replacement of the entire hip joint (eg Charnley)

3.7

50.7

163

447

TCA20

NOMESCO Finland

Peribulbar therapeutic injection into orbit

5.6

50.4

170

NFC40

NOMESCO Finland

Repair of hip prosthesis by bone transplant to acetabulum

4.3

50.4

131

308

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.6

50.3

1275

8182

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

2.3

50.2

392

1732

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

3.7

50.1

157

423

D89.89

ICD-10 Finland

Other specified disorders involving the immune mechanism, not elsewhere classified

10.2

50.1

NDG20

NOMESCO Finland

Fusion of wrist, partial

3.6

50.1

168

474

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.2

50.1

430

1976

A01AB09

ATC

miconazole; local oral

1.4

49.7

1948

13696

-1, ,

NOMESCO Finland

1.2

49.5

8718

75265

NXL00

NOMESCO Finland

Biopsy of muscle

4.3

49.5

128

300

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

49.4

6638

55705

H20

ICD-10 Finland

Iridocyclitis

3.7

49.4

157

427

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

2.7

49.4

274

1034

M30.0

ICD-10 Finland

Polyarteritis nodosa

7.4

49.4

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

3.4

49.3

177

522

L03AA02

ATC

filgrastim; parenteral

1.9

49.1

669

3625

WX892

NOMESCO Finland

Monitored bed care

1.5

49.1

1657

11315

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

1.7

49.0

901

5332

1AA01, ,

NOMESCO Finland

11.3

49.0

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.5

49.0

1549

10438

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.4

48.9

2523

18616

EBA10

NOMESCO Finland

Operative extraction of tooth

1.3

48.9

3175

24287

N05CF01

ATC

zopiclone; oral

1.2

48.8

7614

64904

XCK00

NOMESCO Finland

Perimetry

1.5

48.7

1351

8848

K61.0

ICD-10 Finland

Anal abscess

2.2

48.7

414

1895

M15.3

ICD-10 Finland

Secondary multiple arthrosis

4.6

48.4

115

252

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.6

48.0

1317

8605

NGF10

NOMESCO Finland

Total synovectomy of knee, open

6.4

47.9

124

M02AA10

ATC

ketoprofen; topical

1.3

47.9

3681

28835

A10AC01

ATC

insulin (human); parenteral

1.5

47.9

1561

10582

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.6

47.9

1311

8561

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

47.9

4369

35013

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.6

47.8

1207

7737

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.9

47.8

610

3237

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.4

47.7

2858

21592

1CX01, ,

NOMESCO Finland

7.0

47.7

103

SPAT1204

SPAT

Arthrocentesis

3.1

47.6

197

634

TCF00

NOMESCO Finland

Subconjunctival therapeutic injection

5.6

47.5

162

L52

ICD-10 Finland

Erythema nodosum

3.1

47.5

203

666

C08CA02

ATC

felodipine; oral

1.5

47.4

1846

12961

EB1WA, ,

NOMESCO Finland

3.2

47.4

185

575

JHD33

NOMESCO Finland

Completing incision of fistula-in-ano

5.0

47.4

102

206

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

4.4

47.3

119

273

M35.5

ICD-10 Finland

Multifocal fibrosclerosis

6.9

47.2

104

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

47.2

2586

19262

JHD30

NOMESCO Finland

Incomplete incision of fistula-in-ano

4.8

47.2

105

218

B01AB10

ATC

tinzaparin; parenteral

1.4

46.9

2292

16753

4AB0X, ,

NOMESCO Finland

163.5

46.8

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.6

46.8

1110

7012

R01AD12

ATC

fluticasone furoate; nasal

1.2

46.7

8360

72196

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

46.3

5328

43894

RS224, ,

NOMESCO Finland

3.7

46.2

148

405

N18.0

ICD-10 Finland

End-stage renal disease

2.7

46.2

243

893

M90.7*C90.0

ICD-10 Finland

Pathological fracture in multiple myeloma

10.6

46.1

NHQ40

NOMESCO Finland

Amputation of toe

2.4

45.9

328

1395

NCF15

NOMESCO Finland

Synovectomy of elbow joint, arthroscopic

10.9

45.9

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.3

45.9

2963

22636

M70.6

ICD-10 Finland

Trochanteric bursitis

1.3

45.9

3000

22961

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.5

45.7

1542

10526

6403

FHL

Ileocal resection

11.2

45.7

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.0

45.6

475

2350

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

1.9

45.6

607

3267

K03.66

ICD-10 Finland

Tooth plaque

1.5

45.4

1743

12203

1008, ,

NOMESCO Finland

7.0

45.1

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

45.1

4784

39031

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.0

45.0

472

2341

M30.8

ICD-10 Finland

Other conditions related to polyarteritis nodosa

13.0

45.0

164

Kela drug reimbursment

Fingolimod

4.4

45.0

113

259

115

Kela drug reimbursment

Breast cancer

0.6

44.9

894

14355

SPAT1260

SPAT

Consultation of another employee

1.3

44.9

4198

33718

M09.0*L40.5

ICD-10 Finland

Juvenile arthritis in psoriasis

73.1

44.9

B81

ICPC

Anaemia vit B12/folate deficiency

1.8

44.9

752

4337

D05AX

ATC

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3000494) Fungus identified in Specimen by Culture

5057

29192

1.87

322.70

1.7

1.4

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

748

1604

4.75

321.81

1.3

1.2

15.73

7.55

u/ml

0.89

105

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

766

1678

4.65

321.08

1.3

1.2

80.58

66.53

u/ml

0.50

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

810

1858

4.45

320.47

1.4

1.2

221.67

119.78

titre

0.93

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

766

1683

4.64

319.89

1.3

1.2

51.18

42.57

u/ml

0.46

118

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

781

1743

4.57

319.88

2.3

2.1

14.74

14.55

0.16

759

1701

(3038026) Centromere Ab [Units/volume] in Serum

776

1726

4.58

319.17

1.3

1.2

44.09

52.38

u/ml

0.25

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

810

1864

4.43

319.15

1.4

1.2

222.07

175.90

titre

0.85

242

239

(40761536) Microorganisms panel - Urine sediment

3927

20932

2.00

317.63

5.2

3.7

—

(3047189) Immunofixation for 24 hour Urine

504

758

6.74

317.32

2.7

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1401

4689

3.08

316.38

1.7

1.5

116.11

110.71

u/ml

0.50

282

1037

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1212

3722

3.35

315.89

2.1

1.7

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3218

15978

2.13

315.52

1.3

56.56

50.50

au/ml

0.59

119

819

(3028192) IgG subclass 2 [Mass/volume] in Serum

923

2392

3.94

310.20

1.6

1.3

2.84

2.93

g/l

0.71

651

1675

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

688

1420

4.93

309.82

1.8

1.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

5017

29237

1.85

309.46

2.0

1.7

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

922

2392

3.94

309.39

1.6

1.3

0.40

g/l

0.01

651

1677

(3027135) IgG subclass 1 [Mass/volume] in Serum

922

2394

3.94

309.02

1.6

1.3

7.07

6.64

g/l

1.81

652

1676

(21494815) CD4 cells/100 lymphocytes in Specimen

833

2012

4.22

308.11

2.1

2.3

43.33

37.46

19.07

822

1979

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

6846

4251

20.33

307.65

1.6

1.5

3.16

8.12

iu/ml

0.58

1379

914

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

3398

6637

5.62

307.65

2.4

1.6

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

2029

6000

3.55

307.65

8.7

2.0

10.11

2.02

ratio

1.60

163

472

(3008898) HLA-B27 [Presence]

3265

8203

4.33

307.65

1.1

—

(1175426) CD3 cells/100 lymphocytes in Blood

796

1768

4.59

307.65

2.3

2.1

73.75

72.17

1.80

760

1708

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2096

7390

2.97

307.65

5.1

1.7

10.21

10.11

g/l

0.36

1929

6557

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

16548

109236

2.09

307.65

8.7

5.8

1.22

1.21

mmol/l

8.63

15664

99645

(3011397) Hemoglobin [Presence] in Urine by Test strip

10659

56792

2.33

307.65

5.4

3.3

—

(3013115) Eosinophils [#/volume] in Blood

28636

126128

15.98

307.65

16.5

4.7

0.18

0.19

e9/l

59.78

27422

109898

(3006315) Basophils [#/volume] in Blood

28523

121542

16.23

307.65

16.1

4.4

0.04

e9/l

6.16

27136

104252

(3028026) IgM [Mass/volume] in Serum or Plasma

5145

13154

4.48

307.65

2.4

1.7

1.13

1.35

g/l

12.72

4757

12019

(3034891) Synovial lining cells/100 cells in Synovial fluid

825

753

11.22

307.65

1.7

1.3

4.74

3.52

0.93

220

151

(3034860) Kappa light chains.free [Mass/volume] in Serum

2076

6198

3.51

307.65

8.9

2.1

57.47

67.18

mg/l

0.35

1657

5030

(3029937) Albumin [Presence] in Urine by Test strip

11472

65270

2.19

307.65

6.4

3.6

0.00

estimate

3.70

5311

21434

(3024561) Albumin [Mass/volume] in Serum or Plasma

17335

104063

2.49

307.65

7.7

4.6

35.70

35.88

g/l

4.37

16608

96530

(3031040) Bacteria [#/volume] in Urine by Automated count

20495

166627

1.67

307.65

5.5

4.2

1022.75

1502.74

e6/l

0.47

215

2229

(3042936) Bacteria identified in Isolate by Culture

6331

33707

2.10

307.65

2.3

2.0

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

28915

192257

7.64

307.65

15.4

6.7

73.19

78.14

u/l

108.83

28585

180726

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

2061

4593

4.73

307.65

1.3

1.2

21.08

12.35

u/ml

0.60

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

5277

25789

2.26

307.65

4.6

4.3

242.54

242.38

u/l

0.02

5050

24417

(3004588) Protein electrophoresis panel - Serum or Plasma

4025

13911

3.17

307.65

5.2

1.8

—

(3030467) Casts [#/volume] in Urine by Automated count

11136

66619

2.04

307.65

4.1

3.0

0.30

0.41

e6/l

7.12

9217

49594

(3036481) Cortisol [Moles/volume] in Serum or Plasma

4641

22955

2.20

307.65

2.3

2.2

335.34

377.73

nmol/l

41.14

4368

21114

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

2398

5725

4.45

307.65

1.4

1.2

6.99

5.34

u/ml

0.40

362

522

(3025159) Blasts/100 leukocytes in Blood

7544

16019

5.89

307.65

6.6

3.5

0.17

0.40

1.70

1962

4327

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

953

1638

5.97

307.65

1.2

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1383

3362

4.26

307.65

2.2

1.2

—

(3022096) Basophils/100 leukocytes in Blood

25828

110335

8.68

307.65

16.5

4.6

0.75

0.67

101.20

25423

102355

(3035350) Ketones [Presence] in Urine by Test strip

20256

122563

2.85

307.65

5.5

3.3

0.00

estimate

0.42

5504

23387

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

1962

2009

10.35

307.65

1.9

1.3

50.85

59.90

11.76

1345

1192

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

6586

31539

2.38

307.65

2.9

2.6

22.43

23.09

3.09

5795

26982

(3001122) Ferritin [Mass/volume] in Serum or Plasma

15695

112911

1.78

307.65

3.6

2.8

136.22

118.28

ug/l

9.84

14869

105200

(3015736) pH of Urine

16449

99419

2.38

307.65

4.8

3.1

5.89

5.87

0.17

858

8658

(3004809) Band form neutrophils/100 leukocytes in Blood

1365

3333

4.23

307.65

3.1

3.3

1.04

1.65

9.27

1256

2958

(3002385) Erythrocyte distribution width [Ratio]

26735

227565

2.20

307.65

31.1

14.6

14.91

14.92

0.08

26625

223465

(3048929) Epstein Barr virus Ab [Presence] in Serum

2131

8314

2.68

307.65

1.5

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

2054

6648

3.23

307.65

5.2

1.8

1.36

0.69

g/l

7.76

1789

5731

(3004616) Nuclear Ab [Presence] in Serum

1106

2731

4.16

307.65

1.4

1.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

6197

37007

1.84

307.65

2.2

1.8

—

(3036071) Salmonella sp Ab [Titer] in Serum

484

637

7.70

307.65

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

2414

5821

4.41

307.65

1.4

1.3

14.46

6.28

u/ml

5.08

536

817

(46235355) HIV 1 and 2 tests - Meaningful Use set

9412

49436

2.29

307.65

1.7

1.9

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1534

5065

3.13

307.65

1.7

1.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

10430

67717

1.81

307.65

4.8

3.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

8723

29170

3.76

307.65

1.5

1.7

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

1298

2823

4.75

307.65

1.4

1.2

47.04

55.42

u/ml

0.52

107

175

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

1458

1514

10.05

307.65

1.9

1.3

37.93

27.31

14.68

965

885

(3037522) Nuclear Ab [Titer] in Serum

11969

31863

5.46

307.65

1.6

1.3

625.39

515.11

titre

6.65

3280

5793

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

1502

193

81.66

307.65

3.2

3.9

8.04

8.51

mg/l

0.37

1208

151

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

813

1521

5.46

307.65

2.9

1.5

3.79

3.68

mg/l

0.26

781

1447

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1855

5198

3.73

307.65

1.2

1.3

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

11870

84933

1.64

307.65

4.6

3.1

32.81

33.18

u/l

0.27

11273

80653

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

2084

4632

4.75

307.65

1.4

1.2

4.11

6.37

u/ml

0.66

208

316

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

11109

58574

2.39

307.65

3.0

2.2

3.03

2.87

mg/l

11.11

9998

49968

(3008757) Leukocyte morphology finding [Identifier] in Blood

921

2229

4.22

307.65

3.7

3.5

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

576

964

6.07

307.65

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

2063

6754

3.20

307.65

1.4

1.2

190.27

101.09

titre

2.22

225

594

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

3465

17521

2.10

307.65

2.4

2.3

25.50

23.23

au/ml

0.54

220

1453

(3026493) Urate [Moles/volume] in Serum or Plasma

11706

63242

2.36

307.65

3.3

2.5

1620.60

4177.21

umol/l

22.64

10718

55542

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

379

51.81

307.65

1.8

1.5

1.68

1.77

mg/l

0.23

321

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

19466

102030

3.40

307.65

3.2

2.2

77.22

968.00

nmol/l

0.50

18671

91983

(3023368) Bacteria identified in Blood by Culture

10158

61932

1.95

307.65

5.1

4.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

7043

40878

1.93

307.65

3.3

2.7

0.88

1.21

e6/l

4.11

4659

22495

(3022948) Iron [Moles/volume] in Serum or Plasma

7413

36990

2.31

307.65

2.9

2.5

12.81

14.09

umol/l

1.66

7077

34509

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

950

1622

6.01

307.65

1.2

1.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

6754

16845

4.84

307.65

4.6

2.2

10.68

10.44

g/l

3.18

6391

15348

(3017732) Neutrophils [#/volume] in Blood

4111

16837

2.66

307.65

3.8

2.5

4.94

4.85

e9/l

0.12

3285

13818

(3004789) Transferrin [Mass/volume] in Serum or Plasma

6818

34087

2.28

307.65

2.9

2.5

2.32

2.37

g/l

9.35

6451

31514

(3037467) Urinalysis macro (dipstick) panel - Urine

25414

173121

3.49

307.65

7.5

3.9

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2871

6912

4.47

307.65

2.6

1.5

0.22

0.24

g/l

20.85

2755

6540

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1532

4253

3.73

307.65

1.5

1.2

156.80

113.33

titre

0.48

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

28000

243998

2.40

307.65

21.6

11.5

86.59

83.85

ml/min/173m2

85.58

25299

199593

(3002179) Metamyelocytes/100 leukocytes in Blood

7642

16109

5.95

307.65

5.9

3.3

0.42

0.77

26.76

2274

5171

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

1299

194

69.78

307.65

2.1

1.8

9.33

8.66

mg/l

0.96

1038

154

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

10405

72965

1.64

307.65

2.6

2.1

155.35

209.24

u/l

11.51

9931

68406

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

2079

6179

3.53

307.65

8.9

2.1

59.35

39.30

mg/l

2.37

1660

5013

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

294

74.15

307.65

2.4

2.5

3.24

3.02

mg/l

0.27

283

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1564

5244

3.09

307.65

2.0

1.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1729

5048

3.57

307.65

1.5

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1533

5073

3.12

307.65

2.1

1.6

—

(40760888) Immunoglobulin light chains.free panel - Serum

1684

4575

3.83

307.65

8.6

2.1

—

(3018095) Leukocytes [#/volume] in Urine

14524

85625

2.30

307.65

5.0

3.5

66.01

90.13

e6/l

2.88

10426

59364

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2351

9697

2.54

307.65

1.8

1.7

1.55

1.52

g/l

0.60

2034

8321

(3018418) pH of Serum or Plasma

12041

70563

2.15

307.65

5.9

3.9

7.40

0.05

2530

13241

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1764

5945

3.08

307.65

4.7

1.7

0.03

0.02

g/l

0.22

1629

5443

(3024980) IgG subclass 4 [Mass/volume] in Serum

1452

3747

4.01

307.65

2.0

1.5

0.74

g/l

0.01

1105

2842

(40760892) CBC W Ordered Manual Differential panel - Blood

28175

113563

15.87

307.65

16.3

4.9

—

(3022145) Colonoscopy Study observation

6690

26970

2.88

307.65

1.9

1.3

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

3864

8947

4.78

307.65

1.3

1.2

1.18

0.76

u/ml

1.14

337

772

(3021960) Folate [Moles/volume] in Serum or Plasma

8176

53802

1.70

307.65

1.6

1.5

20.98

20.45

nmol/l

1.42

7208

46218

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1522

5037

3.12

307.65

1.7

1.4

23.62

20.32

u/ml

0.29

104

(3017181) Myelocytes/100 leukocytes in Blood

8098

17805

5.78

307.65

6.4

3.5

0.69

1.02

22.19

2549

5997

(3022217) INR in Platelet poor plasma by Coagulation assay

14506

110472

1.58

307.65

13.2

13.0

1.17

1.22

inr

11.63

4833

32171

(3021440) Promyelocytes/100 leukocytes in Blood

7761

16904

5.77

307.65

6.6

3.5

0.07

0.13

7.80

2212

5133

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1652

4741

3.62

307.65

1.5

1.3

285.75

262.26

u/ml

1.95

997

3097

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

9679

39726

3.08

307.65

1.5

1.7

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

635

364

17.78

307.65

1.8

1.4

8.86

9.35

ug/l

0.94

635

364

(3017354) Segmented neutrophils/100 leukocytes in Blood

864

2024

4.36

307.65

3.1

3.3

57.63

56.39

0.92

756

1701

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

950

1625

6.00

307.65

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

954

1642

5.96

307.65

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

950

1618

6.02

307.65

1.2

1.1

—

(3013707) Erythrocyte sedimentation rate by Westergren method

28569

187497

7.02

307.65

11.0

3.3

13.43

11.26

mm/h

118.80

27958

173377

(3024263) Appearance of Synovial fluid

590

957

6.26

307.65

1.9

1.2

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

2107

6168

3.59

307.65

2.2

1.3

12.45

17.84

iu/ml

0.99

113

(3013650) Neutrophils [#/volume] in Blood by Automated count

28962

142165

14.94

307.65

19.6

7.8

3.93

4.07

e9/l

28.83

27663

123008

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

30447

278636

4.43

307.65

27.1

8.8

26.96

26.63

u/l

2.27

30281

269143

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1938

6317

3.20

307.65

2.6

2.0

10.74

10.82

mg/l

0.16

1816

5898

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

409

116

35.70

307.65

1.1

1.0

—

(3027945) Reticulocytes/100 erythrocytes in Blood

5294

24503

2.40

307.65

3.6

2.5

1.79

1.76

1.14

4893

21691

(3011412) CD3 cells [#/volume] in Blood

1016

2170

4.80

307.65

2.3

2.5

1.08

1.23

e9/l

5.50

901

1936

(3002582) Erythrocytes [#/volume] in Urine

11749

72844

1.98

307.65

4.2

3.1

44.25

83.47

e6/l

4.65

9812

54748

(3037756) Immunofixation for Serum or Plasma

1589

3936

4.20

307.65

2.9

1.4

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1469

3524

4.32

307.65

4.5

2.8

921.73

6388.24

u/ml

1.02

112

185

(3019069) Monocytes/100 leukocytes in Blood

26191

114993

8.84

307.65

17.1

4.8

8.92

8.41

161.83

25805

107294

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

14374

95672

1.93

307.65

6.0

3.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

2725

7531

3.87

307.65

2.1

1.5

391.63

191.39

titre

3.52

196

244

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

11424

39495

3.98

307.65

1.4

1.2

43.81

4.05

u/ml

153.75

4836

15206

(3010144) Erythrocytes [#/volume] in Synovial fluid

1231

1599

7.97

307.65

1.7

1.2

32989.02

151426.90

e6/l

7.55

873

1072

(3020564) Creatinine [Moles/volume] in Serum or Plasma

30402

277373

4.37

307.65

29.1

14.1

75.41

75.01

umol/l

1.17

30395

277272

(3006504) Eosinophils/100 leukocytes in Blood

26130

114268

8.80

307.65

16.5

4.6

2.74

2.88

22.32

25740

106389

(3007164) IgA [Mass/volume] in Serum or Plasma

9256

50799

2.17

307.65

2.1

1.4

2.48

2.33

g/l

7.09

6577

30471

(3010375) cycloSPORINE [Mass/volume] in Blood

684

862

8.09

307.65

26.3

30.0

119.30

120.14

ug/l

0.08

594

708

(36304419) Bacteria [Presence] in Urine

10925

65289

2.03

307.65

4.0

2.9

—

(3000475) Leukocytes [#/volume] in Synovial fluid

3133

4213

8.15

307.65

2.0

1.4

9006.37

15457.71

e6/l

9.83

2462

2922

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1738

6172

2.92

307.65

4.6

1.7

37.05

38.20

g/l

12.04

1575

5373

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

17574

129495

1.81

307.65

7.6

6.0

10.29

11.18

umol/l

25.20

16904

122568

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

3499

4535

8.56

307.65

1.7

1.3

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

3482

9475

4.01

307.65

2.6

1.3

17.44

9.39

u/ml

3.19

279

137

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

4631

16066

3.21

307.65

2.0

1.6

—

(21494890) Protein electrophoresis panel - 24 hour Urine

891

1918

4.75

307.65

3.7

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

1360

3041

4.63

307.65

1.1

1.2

—

(3044941) Cell count panel - Synovial fluid

1937

2780

7.36

307.65

1.6

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2179

7436

3.07

307.65

5.0

1.7

3.04

2.89

g/l

7.96

2026

6644

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2337

4360

5.71

307.65

6.0

512.37

1450.25

iu/ml

1.56

326

662

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2290

7874

3.06

307.65

5.0

1.7

3.71

3.69

g/l

0.15

2137

7084

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2635

7688

3.65

307.65

1.3

1.4

—

(3026782) Osmolality of Urine

7571

47651

1.78

307.65

3.8

2.7

536.23

541.08

mosm/kgh2o

1.13

6795

40649

(3009871) Measles virus Ab [Titer] in Serum

517

677

7.74

307.65

1.7

1.6

—

(3034770) Mitochondria Ab [Titer] in Serum

2031

6650

3.20

307.65

1.4

1.2

912.88

923.32

titre

0.02

205

(3021589) Normoblasts [#/volume] in Blood

20884

110412

3.68

307.65

19.4

8.1

0.00

e9/l

4.68

18998

89392

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

11389

42314

3.66

307.65

1.4

1.2

71.35

24.63

iu/ml

43.36

4831

12714

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1619

5503

3.05

307.65

4.8

1.7

0.00

g/l

0.08

1492

5016

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1594

5431

3.04

307.65

4.9

1.7

0.00

g/l

-0.00

1490

4997

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2905

7155

4.37

307.65

2.5

1.5

1.16

1.18

g/l

4.18

2799

6793

(3023420) DNA double strand Ab [Units/volume] in Serum

1950

1873

11.03

307.65

1.8

1.4

37.42

26.34

iu/ml

1.61

119

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

2653

1485

19.42

307.65

1.1

1.55

2.31

iu/ml

0.99

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

18058

120503

2.18

307.65

9.9

6.4

1.22

mmol/l

4.44

15478

102578

(40761535) Cells panel - Urine sediment

3875

18824

2.21

307.65

5.9

3.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

953

1640

5.96

307.65

1.2

1.1

—

(3023520) Reticulocytes [#/volume] in Blood

4148

17976

2.51

307.65

2.8

2.6

69.41

70.43

e9/l

0.97

3130

13429

(40758558) Short blood count panel - Blood

12718

62426

2.75

307.65

13.2

6.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

361

45.06

307.65

3.3

2.6

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2291

7897

3.05

307.65

5.0

1.7

7.48

7.33

g/l

3.53

2138

7102

(3000850) Epithelial cells [#/volume] in Urine

9230

49657

2.22

307.65

3.3

2.5

4.81

6.05

e6/l

11.94

8574

44159

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1810

4871

3.88

307.65

1.4

1.2

53.82

37.51

u/ml

3.52

278

417

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

1054

151

72.17

307.65

1.8

1.6

122.18

198.01

au/ml

0.83

137

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

1363

183

77.79

307.65

2.7

3.3

158.72

143.07

au/ml

0.20

183

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1393

3261

4.42

307.65

1.1

—

(3018010) Neutrophils/100 leukocytes in Blood

26166

117034

8.54

307.65

16.1

4.5

57.97

56.55

82.10

25777

109427

(3001604) Monocytes [#/volume] in Blood

28502

121281

16.15

307.65

16.1

4.4

0.58

0.57

e9/l

0.74

27128

104138

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

2518

6397

4.19

307.65

1.4

1.2

34.10

38.25

u/ml

0.32

188

352

(3048689) Calprotectin [Mass/mass] in Stool

8585

31098

3.42

307.65

6.0

1.8

206.06

116.08

ug/g

74.06

7785

23926

(3009261) Glucose [Presence] in Urine by Test strip

20371

123979

2.84

307.65

5.5

3.3

0.00

estimate

1.34

5260

21656

(3002030) Lymphocytes/100 leukocytes in Blood

26258

119004

8.50

307.65

16.8

4.6

27.76

28.67

40.95

25871

111378

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2289

7888

3.05

307.65

5.0

1.7

—

(3020630) Protein [Mass/volume] in Serum or Plasma

4510

17417

2.86

307.65

5.3

2.1

66.42

66.65

g/l

1.07

4233

15846

(3021879) Hepatitis B virus core Ab [Presence] in Serum

6198

18247

3.99

307.65

1.3

1.5

—

(3021601) Nitrite [Presence] in Urine by Test strip

20263

122692

2.85

307.65

7.1

4.5

0.00

estimate

1.41

5385

22248

(3021788) Differential panel - Synovial fluid

2580

3124

8.91

307.65

1.8

1.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

30258

261070

5.81

307.65

27.4

12.2

16.74

23.20

mg/l

307.65

27653

202090

(3019198) Lymphocytes [#/volume] in Blood

28560

125625

15.59

307.65

16.3

4.5

1.81

1.97

e9/l

74.43

27395

110527

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2747

10020

2.91

307.65

2.6

1.9

37.52

39.84

u/l

7.14

2531

8899

(4062490) Immunoglobulin typing, IgG

921

2403

3.92

306.58

1.6

1.3

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

742

1648

4.59

305.68

2.3

2.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

726

1588

4.65

304.80

2.5

2.6

433.54

541.22

e6/l

6.49

599

1326

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

778

1804

4.40

303.50

1.2

1.1

80.32

47.45

u/ml

1.17

(40768443) Skin Pathology biopsy report

2355

10527

2.34

298.06

1.3

1.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

705

1540

4.66

296.45

2.5

2.7

0.20

0.24

e9/l

2.80

604

1318

(3010503) CD19 cells [#/volume] in Blood

635

1273

5.07

295.81

2.0

2.8

0.15

0.39

e9/l

1.84

616

1242

(3019150) Specific gravity of Urine by Refractometry

8021

54025

1.65

293.60

6.6

3.6

1.02

kg/l

0.15

1020

8204

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1804

7217

2.59

290.61

2.8

2.6

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

399

519

7.77

286.33

1.8

1.2

46.54

58.45

6.15

357

426

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

12982

98613

1.54

281.08

2.1

1.9

93.48

97.42

pmol/l

19.20

7755

50622

(3003458) Phosphate [Moles/volume] in Serum or Plasma

5155

31205

1.78

277.39

9.3

5.7

1.05

mmol/l

0.17

4912

29172

(3019309) Folate [Moles/volume] in Red Blood Cells

6463

41829

1.69

272.86

1.8

1.7

1177.55

1169.89

nmol/l

0.27

5079

31790

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1161

3828

3.11

268.48

1.7

1.4

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

11155

82955

1.53

260.42

3.4

2.34

2.36

mmol/l

24.25

10120

73222

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1111

3650

3.12

258.40

2.1

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1111

3652

3.12

258.16

2.1

1.6

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

354

452

7.91

258.07

1.5

1.2

41.46

38.75

0.50

263

279

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1924

8410

2.37

255.16

2.1

2.0

2.35

2.20

ug/l

0.07

1721

7459

(3045414) Leukocytes [Presence] in Urine

2293

10856

2.20

251.39

2.0

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4278

25177

1.81

250.85

2.0

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4294

25302

1.81

250.76

2.1

1.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

960

2942

3.33

250.52

1.9

1.5

—

(3045424) Erythrocytes [Presence] in Urine

1152

3937

3.00

250.07

1.5

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

3941

22814

1.83

243.43

3.1

2.3

0.22

g/l

9.91

3733

21286

(3025941) Bacteria identified in Stool by Culture

2845

14835

2.01

241.07

1.4

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

672

1673

4.08

238.41

2.4

2.7

637.69

698.73

e6/l

1.89

648

1624

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

420

705

6.02

237.26

1.9

1.7

7450.45

39494.46

u/ml

0.99

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

8790

63214

1.54

233.27

3.6

2.8

1245.33

1196.51

ng/l

0.42

7648

53424

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

938

2981

3.21

230.51

1.7

1.4

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

572

1296

4.48

229.63

2.2

1.2

6.16

5.67

u/l

0.82

501

1079

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1594

6720

2.44

228.60

1.8

1.7

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

17641

146603

1.46

225.16

6.3

4.5

6.52

6.66

mmol/l

16.31

16791

136477

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1266

4837

2.68

222.74

1.5

1.6

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1045

3612

2.96

222.05

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

884

2774

3.25

221.78

1.6

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

1636

7142

2.36

216.78

3.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

498

1059

4.76

216.23

1.1

1490.56

1514.70

miu/ml

0.16

498

1059

(3017704) Immunofixation for Urine

480

1000

4.86

213.61

2.7

1.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

10501

79500

1.48

213.42

3.3

2.5

59.42

62.15

u/l

0.71

9833

73380

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

789

2363

3.40

213.38

2.0

1.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

990

3414

2.96

211.15

1.8

1.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1469

6224

2.43

208.02

1.5

1.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

3518

20583

1.80

207.50

12.0

7.4

9.32

9.19

mmol/l

0.50

3385

19672

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

954

3259

2.99

206.89

1.6

1.4

—

(3026250) Tacrolimus [Mass/volume] in Blood

480

1050

4.62

201.32

39.7

35.6

6.93

7.43

ug/l

4.86

434

959

(3023103) Potassium [Moles/volume] in Serum or Plasma

28595

266101

1.86

201.31

21.5

14.6

3.93

3.96

mmol/l

38.57

28011

258970

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1127

4276

2.70

200.79

1.7

1.6

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

28528

265319

1.85

200.75

21.1

14.5

139.42

139.69

mmol/l

70.73

28001

258716

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

225

224

10.11

199.16

4.1

2.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

722

2140

3.43

198.42

2.0

1.7

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

779

2434

3.26

196.70

2.0

1.6

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

782

2455

3.24

195.92

1.2

67.39

63.20

u/l

0.31

713

2186

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

5717

38671

1.58

193.20

3.7

2.8

2.71

3.07

e6/l

1.84

3347

20435

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3283

19235

1.79

191.79

5.2

3.7

1.23

mmol/l

0.03

3037

16702

(42529582) MDA5 Ab [Presence] in Serum by Line blot

309

484

6.43

187.05

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

309

484

6.43

187.05

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

309

484

6.43

187.05

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

309

484

6.43

187.05

1.1

—

(3016228) CD19 cells/100 cells in Blood

415

861

4.87

185.59

1.8

2.2

7.34

9.05

2.23

401

842

(3012095) Magnesium [Moles/volume] in Serum or Plasma

5780

39517

1.57

185.53

5.5

3.4

0.80

0.82

mmol/l

17.81

5460

37045

(3026008) Bacteria identified in Urine by Culture

9667

73801

1.45

180.49

3.4

2.9

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3036

17729

1.79

178.64

5.2

3.8

84.40

88.71

ng/l

1.43

2727

15404

(3033658) Prothrombin time (PT) actual/Normal

8604

64396

1.46

177.77

5.7

3.8

92.37

91.95

0.88

8400

62756

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

8142

60300

1.47

177.57

1.3

1.22

1.73

u/ml

5.15

2138

16416

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1243

5244

2.43

177.26

1.5

1.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

401

846

4.79

175.78

1.8

2.1

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

765

2533

3.07

175.08

2.1

1.5

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

765

2533

3.07

175.08

2.1

1.5

—

(3006245) CD3-CD19+ cells/100 cells in Blood

416

950

4.42

165.30

3.1

2.1

9.77

11.64

1.64

381

894

(40768441) Liver Pathology biopsy report

581

1687

3.49

164.80

1.5

1.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

7634

56499

1.46

164.76

2.2

1.7

1.32

1.13

mg/l

3.89

5992

42668

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1127

4711

2.44

163.86

1.7

1.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

30557

293611

2.72

163.51

40.8

18.1

40.11

40.60

11.20

29306

276287

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1446

6746

2.20

162.68

9.2

3.6

1.52

1.45

mg/l

2.66

1354

6237

(3020876) Protein [Mass/time] in 24 hour Urine

704

2320

3.08

162.40

3.8

2.3

0.93

1.44

g/24h

6.05

382

1152

(3013293) Extractable nuclear Ab [Presence] in Serum

226

294

7.73

162.18

1.7

1.6

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1028

4145

2.53

161.47

1.1

—

(3007461) Platelets [#/volume] in Blood

30562

293887

2.70

159.46

40.8

18.1

264.70

254.12

e9/l

139.71

30336

286271

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

221

295

7.53

155.10

1.2

1.3

—

(3035941) MCH [Entitic mass]

30562

294117

2.66

154.94

40.4

18.0

30.66

30.20

307.65

30464

290196

(3010813) Leukocytes [#/volume] in Blood

30565

294195

2.66

154.25

40.7

18.1

6.79

6.66

e9/l

22.57

30281

285774

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

325

641

5.11

154.21

2.3

3.6

—

(3024731) MCV [Entitic volume]

30561

294145

2.66

154.12

40.5

18.0

92.51

90.56

307.65

30462

290210

(3026361) Erythrocytes [#/volume] in Blood

30562

294175

2.66

153.81

40.7

18.0

4.39

4.53

e12/l

307.65

30275

285783

(40761511) CBC panel - Blood by Automated count

29003

274086

1.79

151.95

21.1

11.7

—

(3000963) Hemoglobin [Mass/volume] in Blood

30562

294271

2.64

151.93

40.9

18.2

133.56

136.09

g/l

190.84

30465

290382

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

478

1289

3.75

151.46

2.5

2.8

43.39

38.46

5.44

277

699

(3035947) Staphylolysin Ab [Units/volume] in Serum

426

1062

4.05

150.78

1.1

3.30

3.86

iu/ml

0.68

(3044927) Protein electrophoresis panel - Urine

606

1910

3.21

150.72

1.3

1.2

—

(40768797) Stomach Pathology biopsy report

5050

34905

1.53

150.57

1.3

1.2

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

475

1284

3.74

149.99

3.5

2.3

936.81

1094.89

u/ml

0.66

464

1275

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

504

1423

3.58

149.20

2.2

1.4

25.79

23.45

u/ml

0.51

165

233

(40768804) Tissue Pathology biopsy report

12831

105329

1.37

148.57

2.2

2.0

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

391

935

4.22

146.36

2.7

2.0

27.56

29.16

1.22

369

894

(21494434) Karyotype in Bone marrow

572

1773

3.27

146.23

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

323

675

4.82

143.24

1.8

2.1

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

5244

36886

1.51

143.12

3.2

2.1

29.73

29.72

0.01

5122

35775

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

531

1596

3.37

142.66

1.4

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

984

4133

2.42

141.37

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

199

265

7.55

139.97

1.9

2.8

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

6825

50782

1.44

139.12

1.9

1.6

23770511.69

35506467.70

pmol/l

0.90

5915

42359

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

582

1880

3.13

138.89

1.9

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

582

1880

3.13

138.89

1.9

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

582

1880

3.13

138.89

1.9

1.6

—

(3007916) DNA double strand Ab [Titer] in Serum

188

239

7.90

137.61

1.6

1.2

124.78

192.92

titre

0.27

(3000060) B lymphocytes [#/volume] in Blood

327

715

4.61

137.26

3.0

2.0

197.28

440.22

e6/l

1.30

184

406

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1568

8035

2.00

137.06

2.7

2.3

345.44

559.33

ug/l

1.88

1422

7525

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

562

1811

3.14

134.67

1.8

1.2

—

30.21

u/ml

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3648

24085

1.58

131.92

3.5

3.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

283

568

5.02

131.64

1.4

1.2

40.01

39.71

g/l

0.11

170

287

(3037692) Legionella sp identified in Specimen by Organism specific culture

321

726

4.45

129.18

1.6

1.5

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

465

1369

3.43

129.09

1.3

1.2

80.18

90.67

u/l

1.22

409

1194

(3037121) Protein [Mass/volume] in Urine

1560

8158

1.96

128.45

3.9

3.2

0.32

g/l

0.00

810

3584

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

457

1336

3.45

128.27

1.3

1.2

22.61

22.75

u/l

0.02

397

1143

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

226

383

5.93

126.50

6.6

5.8

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

137

129

10.66

126.12

1.1

32.66

36.29

u/ml

0.12

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

137

129

10.66

126.12

1.1

23.47

25.30

u/ml

0.09

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

162

192

8.47

125.66

1.4

1.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

4204

28982

1.52

124.54

4.0

2.7

7.24

8.16

umol/l

2.17

3651

25021

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

11111

90901

1.34

124.41

3.9

3.3

116.71

52.96

ng/l

0.76

7533

57631

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

3080

19811

1.61

123.80

3.1

2.5

67.41

67.92

ml/min/173m2

0.27

1259

7621

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

27.72

122.75

7.3

3.4

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

468

1433

3.30

122.05

1.6

1.5

6.29

6.92

u/l

0.39

385

1135

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

424

1232

3.47

120.15

1.5

1.2

97.02

68.60

titre

0.44

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

678

2580

2.66

119.73

1.3

1.2

—

(3042631) Mycobacterium sp identified in Specimen

728

2872

2.57

119.48

2.8

2.5

—

(3005322) IgE [Units/volume] in Serum or Plasma

2719

17100

1.65

119.46

1.4

1.3

412.36

217.85

u/ml

4.27

2540

15825

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

696

2695

2.62

118.68

2.1

2.2

33.07

32.51

2.55

686

2675

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

429

1271

3.41

117.94

1.5

1.2

417.59

501.41

titre

0.18

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

100

15.91

117.05

5.2

2.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

267

564

4.76

116.95

1.3

1.2

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

102

15.26

116.81

5.4

2.5

—

(40768446) Kidney Pathology biopsy report

357

949

3.79

115.54

2.0

1.7

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

134

145

9.27

111.60

4.4

2.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

748

3088

2.46

111.48

1.6

1.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

900

4030

2.27

111.45

1.3

1.2

4.57

3.44

u/ml

0.79

368

1352

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

5827

43664

1.41

110.34

2.8

3.0

2.45

mmol/l

2.95

5181

38152

(3024522) Salmonella sp identified in Specimen by Organism specific culture

746

3097

2.44

109.83

1.7

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

758

3170

2.42

109.81

1.6

1.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

14046

120338

1.30

108.10

3.1

2.5

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

481

1613

3.01

107.62

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

735

3064

2.43

107.22

1.6

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

734

3068

2.42

106.45

1.6

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1623

9128

1.82

106.26

1.7

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

532

1901

2.83

106.07

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

115

108

10.68

106.06

9.9

2.6

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

732

3062

2.42

105.98

1.6

1.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

372

1078

3.48

105.89

1.2

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

480

1624

2.98

105.72

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

558

2061

2.74

104.47

1.2

1.1

45.87

40.35

mg/l

2.00

462

1738

(21491868) Cryoglobulin [Mass/volume] in Serum

306

794

3.88

102.55

1.3

1.2

0.61

0.33

g/l

0.54

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

118

121

9.78

102.28

4.1

1.5

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

500

1773

2.85

101.14

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

554

2075

2.70

100.94

1.1

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

370

1106

3.37

100.34

1.1

215.19

201.06

iu/ml

0.26

364

1098

(3000012) Reticulocyte production index

694

2906

2.42

100.24

2.1

2.2

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

537

1987

2.73

100.19

1.1

241.84

260.59

mg/l

1.46

464

1755

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

476

1659

2.90

99.40

1.7

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

404

1285

3.17

99.01

1.7

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2144

13291

1.66

98.91

1.8

1.6

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

852

3920

2.21

98.71

1.3

1.2

3.88

3.89

u/ml

0.01

402

1738

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

138

181

7.65

98.42

4.3

4.1

2.19

2.17

mg/l

0.04

109

162

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

684

2879

2.41

97.66

2.5

—

(3002032) Base excess in Venous blood by calculation

3184

21760

1.51

96.44

7.4

4.0

1.83

1.86

mmol/l

0.16

2746

18589

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

653

2712

2.44

96.03

1.3

1.2

—

(3012544) pH of Venous blood

3278

22577

1.50

95.61

7.3

3.9

7.37

7.38

0.21

173

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3184

21828

1.51

94.93

7.4

3.9

5.79

5.84

kpa

2.16

3094

21207

(3042733) HLA Ab [Presence] in Serum

308

855

3.63

93.63

4.4

5.0

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2367

15255

1.60

93.06

6.2

3.6

5.06

5.15

kpa

7.64

2274

14465

(3028433) Virus identified in Specimen by Culture

282

751

3.78

91.11

1.2

—

(3009343) pH of Capillary blood

2335

15076

1.59

91.02

6.2

3.6

7.42

0.49

351

1876

(3000991) Gas panel - Venous blood

2967

20217

1.52

90.82

12.4

8.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

360

1129

3.21

90.36

2.2

1.9

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

299

834

3.61

90.26

1.1

—

(3023419) Bacteria identified in Sputum by Culture

731

3283

2.25

89.82

2.3

2.6

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

448

1598

2.83

89.66

1.7

1.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

361

1142

3.18

89.32

1.8

1.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

752

3425

2.22

89.30

1.1

1.52

1.49

g/l

1.63

704

3088

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

358

1128

3.20

89.17

2.2

1.9

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

333

1007

3.33

88.70

3.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

362

1152

3.17

88.68

1.8

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2252

14583

1.59

86.53

6.2

3.6

1.55

1.66

mmol/l

0.79

1684

10774

(3045142) Bone marrow Pathology biopsy report

590

2455

2.43

86.42

1.3

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1180

6410

1.87

86.08

1.9

1.3

538.55

523.93

mg/l

0.14

1139

6102

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

181

358

5.08

85.76

1.7

1.3

—

(3048879) Bone marrow aspiration report

227

542

4.21

85.30

2.0

1.9

—

(3024932) HLA-DR beta [Type]

292

836

3.51

84.76

1.1

—

(3024471) HLA-A [Type]

296

856

3.48

84.61

1.0

—

(3019225) pH of Specimen

3341

23633

1.46

84.57

6.1

4.0

—

(42529406) Shigella sp [Presence] in Stool by Culture

1323

7500

1.80

84.02

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1320

7481

1.80

83.91

1.2

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

607

2609

2.35

82.67

1.1

45.40

67.09

au/ml

—

(3041672) Baker's yeast Ab [Presence] in Serum

107

9.27

82.55

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1305

7428

1.79

81.73

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1340

7723

1.77

80.40

5.0

2.6

3.53

3.57

g/l

0.41

1279

7358

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3308

23603

1.45

79.69

2.9

2.5

40.03

45.31

u/l

0.46

2905

20205

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

391

1382

2.85

79.63

1.2

1.1

1.06

1.08

u/l

0.23

190

613

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1053

5660

1.89

79.32

2.0

1.2

3.64

3.74

mmol/l

2.23

993

5317

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

294

886

3.34

78.80

2.3

2.0

—

(3013727) Leukocytes other/100 leukocytes in Blood

252

687

3.69

78.76

3.9

3.2

52.34

52.41

0.02

243

668

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

291

872

3.36

78.70

2.3

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

291

872

3.36

78.70

2.3

2.0

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

3630

26409

1.42

78.55

8.6

7.3

5.02

5.10

kpa

6.37

3468

25263

(3027801) Oxygen [Partial pressure] in Arterial blood

3627

26393

1.42

78.37

8.6

7.3

12.22

12.72

kpa

6.66

3470

25237

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

303

936

3.26

78.03

2.9

2.8

—

(3044640) Blood type and Crossmatch panel - Blood

9549

80183

1.27

77.61

3.1

2.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

7477

60877

1.30

77.48

3.0

2.3

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

607

2685

2.28

77.34

2.4

2.3

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1400

8279

1.72

76.64

4.6

2.3

93.62

92.64

0.89

1358

7935

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1851

11778

1.61

76.27

9.0

4.3

24.05

24.14

mmol/l

0.71

1827

11547

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

169

352

4.82

75.43

1.2

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1589

9773

1.66

75.04

2.3

1.9

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

148

276

5.38

74.97

11.1

9.2

0.50

0.38

umol/l

0.79

113

263

(3019060) Gas panel - Arterial blood

2238

14931

1.54

74.95

4.7

5.0

—

(3010838) Calcium [Moles/time] in 24 hour Urine

878

4531

1.96

74.70

2.0

1.9

4.88

5.26

mmol/24h

2.85

796

4025

(3016502) Oxygen saturation in Arterial blood

3270

23547

1.43

74.64

9.1

7.7

95.60

95.83

1.32

3160

22668

(3020961) Endomysium IgA Ab [Titer] in Serum

1999

13056

1.57

73.61

1.1

182.41

204.76

titre

0.13

344

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

546

2359

2.34

73.51

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1035

5668

1.85

73.50

2.1

1.4

29.51

31.19

e6/l

0.05

821

4377

(3014111) Lactate [Moles/volume] in Serum or Plasma

2930

20731

1.46

73.43

9.6

7.0

1.31

1.34

mmol/l

0.89

2857

20241

(3003396) Base excess in Arterial blood by calculation

3598

26428

1.41

73.35

8.7

7.3

1.05

1.03

mmol/l

0.15

2902

21179

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1035

5673

1.85

73.29

2.2

1.4

1242.13

2565.82

e6/l

0.72

859

4607

(3044290) Cell count panel - Cerebral spinal fluid

983

5310

1.88

72.88

2.2

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

6510

52584

1.30

70.48

1.6

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

341

1203

2.85

69.75

1.2

1.1

27.64

10.22

u/ml

0.74

114

(3001729) Color of Synovial fluid

100

135

7.42

69.61

2.5

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

973

5331

1.85

68.97

2.6

2.1

127.11

131.00

g/l

4.37

622

3935

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1452

8914

1.66

68.96

2.0

1.8

—

(3000093) Morphology [Interpretation] in Blood Narrative

507

2183

2.34

68.82

1.2

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

645

3072

2.12

68.43

7.5

6.2

11.49

11.38

mg/l

0.21

603

2817

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

151

313

4.84

67.82

2.2

2.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

307

1063

2.91

65.02

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

307

1063

2.91

65.02

1.6

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

396

1566

2.55

64.77

1.2

1.1

1.07

ratio

0.32

162

542

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1263

7606

1.69

64.51

4.4

2.5

199.27

183.16

8.75

1202

7205

(3036489) Thrombin time

1542

9774

1.61

64.33

3.8

2.1

21.97

21.38

2.12

1365

8469

(3032352) Blasts [#/volume] in Cerebral spinal fluid

121

221

5.49

62.76

4.9

1.6

—

(4035726) Immunohistochemistry procedure

2996

21867

1.41

62.72

1.5

1.4

—

(3024354) Oxygen [Partial pressure] in Venous blood

2535

17959

1.45

62.61

6.9

3.3

4.73

4.67

kpa

0.76

2449

17393

(3001964) Herpes simplex virus Ag [Presence] in Specimen

238

727

3.29

62.52

1.7

1.5

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2210

15263

1.48

62.27

12.3

7.1

24.74

24.82

mmol/l

0.52

2193

15137

(1616796) Gas panel - Central venous blood

940

5283

1.80

61.29

4.6

3.5

—

(3042951) Complement C1q Ab [Units/volume] in Serum

8.67

61.00

1.4

1.1

22.55

18.60

u/ml

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

85.23

60.88

1.2

1.3

28.83

22.81

mg/l

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2601

18607

1.43

60.86

3.5

2.8

173.79

180.32

ng/l

0.36

2364

16886

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2033

13873

1.50

60.75

1.6

1.5

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

187

498

3.77

60.58

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

328

1226

2.69

60.16

1.2

1.1

22.72

23.91

u/l

0.11

313

1096

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

328

1226

2.69

60.16

1.2

1.1

77.43

84.54

u/l

0.84

313

1098

(40758292) HTLV I+II Ab panel - Serum

153

356

4.31

59.61

1.6

1.3

—

(3036603) Volume of Urine

389

1587

2.47

59.59

2.3

1.4

1912.58

1954.72

0.42

383

1543

(40767503) Oxygen content in Capillary blood by calculation

892

4986

1.81

59.22

3.0

2.4

16.18

16.59

2.02

484

2544

(3035611) Eosinophils/100 leukocytes in Synovial fluid

112

7.51

59.14

2.8

1.2

0.44

0.85

0.87

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2972

21886

1.39

58.84

9.7

8.1

118.68

122.02

g/l

15.74

2903

21293

(3022313) Gas panel - Capillary blood

1668

11000

1.54

58.48

6.9

3.8

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

104

176

5.92

58.48

1.0

1.1

4.21

5.28

u/ml

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1214

7426

1.66

58.35

5.2

3.2

0.34

0.35

u/ml

0.60

684

4224

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

413

1751

2.38

58.13

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

411

1739

2.38

58.11

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

886

4995

1.80

57.17

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

886

4996

1.80

57.13

1.4

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

294

1067

2.77

57.11

1.6

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

294

1067

2.77

57.11

1.6

1.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

823

4544

1.83

56.89

4.0

3.1

—

(3014051) Protein [Presence] in Urine by Test strip

1064

6338

1.70

56.55

3.0

2.3

—

(3029075) Extractable nuclear Ab panel - Serum

229

730

3.15

56.12

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

354

1424

2.50

55.92

1.6

1.4

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

327

1267

2.60

55.85

1.5

17.77

26.63

umol/l

8.09

314

1207

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

350

1402

2.51

55.79

1.6

1.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

998

5879

1.72

55.24

7.7

3.5

8.72

8.54

kpa

2.05

980

5733

(3015235) Bicarbonate [Moles/volume] in Capillary blood

992

5843

1.72

54.93

4.9

2.9

24.29

24.73

mmol/l

2.90

976

5709

(3027315) Oxygen [Partial pressure] in Blood

935

5439

1.74

54.14

4.9

3.8

8.70

8.72

kpa

0.13

920

5316

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

251

868

2.91

53.38

1.1

—

(3010421) pH of Blood

1039

6251

1.68

53.19

4.8

3.8

7.42

3.83

965

5698

(36660697) Celiac disease serology panel - Serum

2918

21768

1.37

53.10

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

342

1392

2.47

52.71

1.2

—

(3013290) Carbon dioxide [Partial pressure] in Blood

923

5409

1.73

52.05

4.9

3.8

4.92

5.02

kpa

4.69

908

5287

(3012501) Base excess in Blood by calculation

922

5408

1.73

51.83

4.9

3.8

2.32

2.49

mmol/l

1.34

662

3631

(3020891) Body temperature

1408

9183

1.56

51.79

5.1

5.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

694

3760

1.86

50.98

1.4

1.3

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1794

12402

1.47

49.98

3.4

2.6

0.20

0.28

e6/l

4.08

1752

12038

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

446

2084

2.16

49.80

3.7

3.8

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1467

9779

1.52

48.80

7.0

3.9

24.62

24.80

mmol/l

1.86

1387

9110

(3014007) Fractional oxyhemoglobin in Arterial blood

2066

14733

1.43

48.79

11.1

9.2

93.80

94.02

0.96

2058

14680

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1615

11013

1.49

48.16

1.1

13.25

10.85

u/ml

0.11

152

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

21731

204297

1.21

47.94

4.1

4.0

14.89

14.68

pmol/l

30.07

20090

187126

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

25341

241985

1.25

47.82

4.8

4.7

1.85

2.12

mu/l

8.38

23640

223767

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

237

844

2.82

47.81

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

544

2783

1.97

47.53

2.1

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

19361

180164

1.19

47.46

3.2

3.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

180

553

3.27

46.98

1.2

1.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

149

407

3.67

46.64

3.0

2.5

58.99

48.92

mg/l

0.16

(3021901) Oxygen saturation in Capillary blood

734

4158

1.78

46.62

4.1

2.7

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

111

245

4.54

46.33

1.6

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

183

573

3.21

46.30

1.2

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

416

1960

2.14

45.52

1.1

288.21

289.73

mg/l

0.15

384

1756

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

125

309

4.06

45.06

1.8

1.6

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1994

14340

1.42

44.81

7.2

24.60

mmol/l

0.00

1904

13651

(3028271) Lactate [Moles/volume] in Capillary blood

670

3739

1.81

44.76

2.1

1.8

1.67

1.73

mmol/l

0.89

653

3652

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

5593

46514

1.25

44.52

4.2

3.5

387.48

490.80

ng/l

0.85

4169

34013

(3012565) Volume of 24 hour Urine

292

1198

2.45

44.33

3.1

2.0

2033.39

1976.47

0.40

270

1065

(3044889) 12 lead EKG panel

19046

177452

1.19

44.24

3.9

3.5

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2029

14689

1.41

43.87

11.1

9.1

1.32

1.39

2.42

2012

14596

(3020393) Adenovirus Ag [Presence] in Stool

120

294

4.09

43.80

2.1

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

705

4025

1.77

43.61

1.2

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2020

14667

1.40

42.90

11.2

9.2

0.70

0.67

2.24

2004

14583

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

351

1583

2.23

42.88

1.2

1.1

—

(3023410) Appearance of Cerebral spinal fluid

507

2641

1.93

42.06

3.0

1.5

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

203

4.69

41.30

1.1

—

(3051651) Icteric interference index of Serum or Plasma

325

1459

2.24

40.19

4.5

3.8

—

(3022621) pH of Urine by Test strip

2175

16162

1.37

40.09

3.8

2.7

—

(3051611) Lipemic interference index of Serum or Plasma

484

2536

1.92

39.49

4.1

3.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

677

3935

1.74

39.36

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2535

19340

1.34

39.31

2.3

8.89

7.13

ug/l

1.67

2214

16915

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

309

1374

2.26

39.11

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

242

967

2.51

38.94

4.2

3.9

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

206

762

2.71

38.76

1.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

119

317

3.76

38.72

1.2

1.5

8.06

304605.09

nmol/l

2.33

261

(3013005) Retinol [Moles/volume] in Serum or Plasma

272

1150

2.38

38.71

2.5

1.9

2.05

1.92

umol/l

1.27

259

1080

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1494

10468

1.45

38.64

5.2

3.0

0.69

0.65

3.01

1486

10428

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

323

1474

2.20

38.39

1.4

13.57

12.34

u/l

1.58

311

1431

(3018405) Lactate [Moles/volume] in Arterial blood

1190

7982

1.51

38.36

3.9

4.3

1.33

1.37

mmol/l

0.81

1167

7845

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

124

344

3.61

38.03

5.6

4.6

40.35

43.31

ug/min

0.22

103

264

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

205

4.50

38.02

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

393

1942

2.04

37.96

1.3

1.2

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

168

563

2.99

37.96

1.1

7.12

6.69

mg/g

0.35

159

531

(3013512) EKG study

7998

69860

1.19

37.84

3.8

3.7

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1227

17722

0.68

37.28

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1981

26354

0.73

37.03

1.6

1.7

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

213

821

2.60

36.96

1.3

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1893

13949

1.38

36.67

1.4

—

(3022806) Fractional oxyhemoglobin in Capillary blood

545

3042

1.80

36.46

1.9

1.8

90.13

89.96

0.34

533

2993

(3012516) Albumin [Mass/volume] in Urine

8071

70738

1.19

36.46

4.0

3.2

1033.02

369.12

mg/l

14.22

5526

44496

(3004119) Hemoglobin [Mass/volume] in Venous blood

1880

13864

1.38

36.23

5.7

3.4

125.23

129.91

g/l

15.95

1830

13548

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1508

10715

1.43

36.11

5.1

3.0

1.24

1.31

2.03

1498

10661

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

475

2561

1.87

35.55

1.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1687

12265

1.40

35.42

12.0

9.4

24.36

24.31

mmol/l

0.29

1629

11911

(3008536) Aspergillus sp Ab [Presence] in Serum

143

456

3.14

35.23

2.3

2.2

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

251

1083

2.33

34.17

2.5

1.9

27.29

29.00

umol/l

1.74

246

1041

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1024

6831

1.52

33.88

1.2

1.1

—

(3009508) Creatinine [Moles/volume] in Urine

8771

77868

1.17

33.34

3.8

3.2

7.44

7.68

mmol/l

4.99

7640

66229

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

6.43

33.11

1.0

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

19035

179157

1.16

33.03

4.0

3.0

51.11

45.80

u/l

11.08

18009

168196

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1072

7261

1.49

32.96

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

232

983

2.37

32.94

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1078

7326

1.49

32.60

1.5

1.4

279.63

278.02

ug/g

0.09

623

4203

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

326

1593

2.06

32.55

3.8

2.1

100.57

96.97

1.01

314

1477

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

290

1364

2.14

32.04

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

139

466

2.99

31.48

1.4

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1261

8899

1.43

31.33

1.3

218.79

223.74

miu/ml

0.17

469

4205

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

439

2413

1.83

30.96

1.4

1.6

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

358

1859

1.94

30.13

1.4

12.62

11.89

umol/l

1.30

350

1763

(3027273) Bicarbonate [Moles/volume] in Venous blood

1480

10819

1.39

30.01

4.7

3.4

25.22

25.26

mmol/l

0.20

1437

10481

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

634

3897

1.64

29.96

1.1

121.95

118.45

1.74

591

3515

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

399

2153

1.86

29.87

3.1

2.8

—

(1761868) Lipid panel - Serum or Plasma

8791

97600

0.86

29.12

2.6

2.7

—

(3005011) Chlamydia sp Ab [Titer] in Serum

110

338

3.26

28.91

1.4

1.6

—

(21494755) Public health laboratory ask at order entry panel

2338

29369

0.78

28.27

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

645

4045

1.61

28.12

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

106

5.29

28.11

1.0

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

159

610

2.61

28.00

1.6

2.0

21.95

39.86

u/l

1.91

136

550

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

327

1691

1.94

27.91

1.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

999

6926

1.46

27.31

4.1

4.6

3.87

3.86

mmol/l

0.03

988

6871

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

227

1034

2.20

27.28

1.1

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

163

642

2.55

27.21

1.2

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

219

989

2.22

26.89

1.1

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

486

2869

1.70

26.86

1.1

96.30

95.52

0.26

458

2694

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

486

2873

1.70

26.72

1.1

—

(3034426) Prothrombin time (PT)

202

887

2.28

26.53

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

160

634

2.53

26.40

1.2

1.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

605

3800

1.60

26.24

1.9

2.1

6.79

8.02

titre

0.09

104

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

363

1983

1.84

26.20

1.2

1.3

2.14

2.05

mmol/l

0.39

339

1841

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

180

756

2.39

26.19

1.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

8277

74273

1.15

25.87

4.4

3.8

12.62

8.80

mg/mmol

1.16

5543

46408

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

405

2300

1.77

25.71

1.7

1.3

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

225

1047

2.16

25.67

4.0

5.2

2297.12

2349.13

mg/l

0.01

185

760

(3009015) Lactate [Moles/volume] in Synovial fluid

222

3.65

25.44

1.5

1.2

5.47

5.98

mmol/l

0.41

106

(3003181) Sodium [Moles/volume] in Urine

615

3908

1.58

25.41

1.5

1.4

65.16

63.87

mmol/l

0.31

494

3090

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1100

7871

1.41

25.30

1.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

24402

235563

1.16

24.89

5.6

5.4

38.56

39.36

mmol/mol

36.91

23032

219124

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

10.00

24.67

1.1

1.0

37.73

—

iu/ml

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

127

468

2.72

24.29

1.3

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1659

12756

1.32

24.08

12.9

9.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

224

1071

2.10

23.87

1.1

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

156

642

2.44

23.80

1.2

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

203

939

2.17

23.56

1.1

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

278

1446

1.93

23.42

1.1

10.21

3.65

nmol/l

1.72

258

(3000330) Specific gravity of Urine by Test strip

1536

11736

1.32

23.31

3.8

3.3

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1333

9990

1.35

23.08

5.0

3.9

49.58

48.91

0.45

1312

9889

(3047007) Chlamydophila sp Ab [Presence] in Serum

610

3994

1.54

22.14

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

245

3.31

21.95

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

152

646

2.36

21.64

1.2

1.1

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

270

3.15

21.28

2.6

1.2

61.61

87.57

u/ml

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

255

3.22

21.26

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

267

1418

1.89

21.18

1.3

19.31

13.59

u/l

1.27

249

1308

(3017569) Oxygen content in Arterial blood

199

960

2.08

20.79

2.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

266

1420

1.88

20.78

1.1

1.2

—

(3000492) Spirometry study

3163

26668

1.21

20.55

1.7

1.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

142

601

2.37

20.44

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

4.65

19.99

1.0

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

210

3.38

19.97

1.2

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

202

997

2.03

19.86

1.2

1.1

358.21

717.28

ng/l

0.78

222

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

224

1150

1.95

19.70

4.7

1.9

54.53

181.98

ug/l

1.04

216

1090

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

134

4.03

19.59

3.4

5.2

—

(40765096) Chromosome analysis panel by Banding

145

636

2.28

19.26

1.2

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

107

4.40

19.08

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

249

1341

1.86

18.97

1.6

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

314

1815

1.74

18.90

1.3

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

163

758

2.16

18.79

1.6

1.8

—

(3036048) Francisella tularensis Ab [Titer] in Serum

132

565

2.34

18.57

1.2

1.1

704.00

589.33

titre

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

489

3175

1.55

18.52

1.5

1.8

12977.78

3233.24

titre

—

142

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

238

1274

1.87

18.50

1.3

60.97

64.64

0.22

149

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

3533

30408

1.18

18.10

8.1

6.4

—

(4200892) Spirometry reversibility

2244

18512

1.23

18.10

1.5

1.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1603

12739

1.27

18.03

2.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

3551

30641

1.18

17.62

1.9

2.0

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1225

9435

1.31

17.58

5.6

5.1

1.62

1.71

2.34

1152

8829

(3023183) Ammonium ion [Moles/volume] in Plasma

724

5138

1.42

17.56

3.0

2.8

32.77

34.32

umol/l

1.23

672

4663

(3032057) Clostridioides difficile [Presence] in Stool

113

463

2.44

17.55

2.0

1.7

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

132

3.87

17.50

1.1

1.0

—

(3012441) Differential panel - Pleural fluid

345

2090

1.66

17.49

1.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

342

2.69

17.45

1.7

1.6

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

197

1017

1.94

17.13

1.1

—

(4034850) Laboratory test

1071

8125

1.33

17.13

12.5

8.8

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

388

2.56

16.91

2.0

1.2

884.88

107.44

ng/l

0.47

248

(3003434) Protein [Mass/volume] in Pleural fluid

420

2696

1.56

16.79

1.5

1.4

34.69

33.64

g/l

0.89

390

2440

(3016244) Insulin [Units/volume] in Serum or Plasma

305

1812

1.69

16.68

3.2

23.97

27.60

mu/l

0.85

293

1700

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

3876

33873

1.16

16.32

2.0

2.1

—

(3047181) Lactate [Moles/volume] in Blood

995

7530

1.33

16.20

6.2

5.8

1.32

1.30

mmol/l

0.32

878

6668

(3018133) Calcium [Moles/volume] in Urine

111

469

2.37

16.15

1.9

2.3

2.40

2.70

mmol/l

0.83

419

(3024928) Oxygen saturation in Venous blood

696

4985

1.40

16.06

7.1

3.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

130

592

2.20

15.88

1.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

4.38

15.83

1.4

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

120

531

2.26

15.71

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

1189

9266

1.29

15.65

5.8

5.1

0.89

0.91

0.79

1118

8678

(3022229) Phosphate [Moles/volume] in Urine

172

3.32

15.62

1.8

2.6

19.47

19.78

mmol/l

0.03

148

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

224

2.99

15.49

1.6

1.08

1.98

mg/l

1.04

152

(3023199) Leukocytes [#/volume] in Pleural fluid

382

2450

1.57

15.38

1.5

3068.86

3578.94

e6/l

0.29

265

1770

(3016038) Potassium [Moles/volume] in Urine

258

1499

1.73

15.36

1.4

31.86

34.66

mmol/l

1.20

219

1298

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

128

589

2.18

15.26

1.7

1.5

0.29

0.42

ug/l

5.11

386

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

320

2.63

15.24

1.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

302

1834

1.65

15.24

1.4

1.3

536.31

502.27

u/l

0.20

291

1742

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1016

13137

0.77

15.19

1.5

—

(3036782) Glucose [Moles/volume] in Pleural fluid

313

1926

1.63

15.00

1.4

1.3

5.91

6.35

mmol/l

1.89

286

1781

(3049717) Cytology report of Urine Cyto stain

1058

8166

1.31

14.99

2.4

2.6

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

219

2.97

14.85

1.6

1.85

2.35

mg/l

0.25

150

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

219

2.97

14.85

1.6

1.80

1.07

mg/l

0.40

141

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

219

2.97

14.85

1.6

2.94

2.85

mg/l

0.04

153

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

219

2.97

14.85

1.6

0.82

2.31

mg/l

3.29

167

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

219

2.97

14.85

1.6

3.67

4.14

mg/l

0.18

147

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

219

2.97

14.85

1.6

0.51

1.12

mg/l

1.76

152

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

219

2.97

14.85

1.6

1.95

2.75

mg/l

0.58

160

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

219

2.97

14.85

1.6

1.66

1.72

mg/l

0.04

142

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

219

2.97

14.85

1.6

1.38

1.70

mg/l

0.39

161

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

527

3661

1.45

14.46

1.2

1.3

44.58

33.13

u/l

1.71

475

3187

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

131

622

2.11

14.45

1.2

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1003

7728

1.31

14.41

1.1

5.88

6.06

u/ml

0.03

1066

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

251

2.79

14.30

1.2

—

(3004451) EKG impression Narrative

190

1034

1.84

14.16

1.4

1.3

—

(3015183) Erythrocyte sedimentation rate

237

1377

1.73

14.15

1.3

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

7382

67820

1.12

14.13

1.7

1.39

1.38

mmol/l

0.46

6358

57267

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

121

567

2.14

13.83

1.8

1.2

—

(3010937) Rubella virus Ab [Presence] in Serum

146

3.36

13.75

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

123

3.58

13.60

3.1

3.4

—

(3016750) Collection duration of Urine

230

1341

1.72

13.59

2.7

2.2

504.38

497.93

min

0.43

183

1015

(3050129) First trimester maternal screen panel - Serum or Plasma

655

8861

0.73

13.50

1.5

1.4

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

210

2.91

13.45

1.2

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

420

2.31

13.44

1.2

1.4

8.60

188.67

titre

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

337

2.47

13.27

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

133

657

2.03

13.24

1.2

1.3

16.88

16.97

umol/l

0.06

119

584

(40757373) Influenza virus identified in Isolate

101

450

2.25

13.10

2.0

1.6

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

286

4481

0.63

13.06

2.6

3.7

22.44

39.36

u/ml

6.35

274

4331

(40768806) Pleura Pathology biopsy report

326

2100

1.56

12.97

1.6

1.5

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

228

1345

1.70

12.94

1.8

1.7

1.51

2.60

u/field

2.70

156

967

(3045788) Cell count panel - Pleural fluid

298

1882

1.59

12.92

1.5

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

599

4346

1.39

12.90

1.1

13.05

11.32

au/ml

0.21

279

(3044009) aPTT.lupus sensitive (LA screen)

233

2.75

12.76

1.2

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

430

2.26

12.75

1.0

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

800

10420

0.76

12.68

3.4

1.6

6.94

3.70

mg/l

4.95

664

7532

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

650

4796

1.36

12.62

3.1

3.4

271.16

924.71

u/ml

2.77

586

4369

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

319

2.45

12.31

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

393

2.29

12.27

1.1

3.87

3.41

pmol/l

0.13

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

506

7018

0.72

12.25

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

506

7013

0.72

12.19

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

392

2667

1.48

12.08

4.2

8.8

7.34

mmol/l

0.01

329

2186

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

506

7000

0.72

12.06

1.4

—

(3019174) dRVVT (LA screen)

229

2.71

12.05

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

504

6970

0.72

11.99

1.4

—

(3052592) Norovirus Ag [Presence] in Stool

442

2.20

11.96

1.6

1.3

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

120

3.42

11.87

7.3

10.9

394.91

147.53

e6/l

0.52

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

5.83

11.77

5.0

3.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

337

2238

1.51

11.71

1.5

50626.43

51393.05

e6/l

0.02

187

1330

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

114

558

2.05

11.70

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2662

30425

0.86

11.51

1.7

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

5.68

11.45

1.0

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

5.68

11.45

1.1

1.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

133

3.23

11.43

1.0

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

679

5126

1.33

11.38

1.3

1.4

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

262

4047

0.64

11.28

4.5

5.3

349.80

373.32

umol/l

1.99

218

3534

(3034274) Bile acid [Moles/volume] in Serum --fasting

491

3540

1.39

11.06

3.2

2.1

10.50

7.05

umol/l

1.97

368

2590

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

263

2.51

11.06

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

232

1436

1.62

11.02

1.5

1.6

8.04

8.43

ug/l

0.09

208

1308

(3045716) Anion gap in Serum or Plasma

174

1001

1.74

10.90

2.8

2.5

9.33

9.91

mmol/l

1.60

168

971

(3035637) Corticotropin [Mass/volume] in Plasma

470

3378

1.40

10.80

1.6

1.5

—

(3002256) Pathology report gross observation

3742

33522

1.13

10.75

1.3

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

206

2.67

10.46

1.2

1.1

19.76

21.58

u/l

0.33

138

(3035880) pH of Pleural fluid

184

1089

1.69

10.43

1.3

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

145

804

1.81

10.32

1.2

—

(3039000) Anion gap in Blood

682

5229

1.31

10.29

7.5

6.8

11.22

11.19

mmol/l

0.09

621

4708

(3018572) Chloride [Moles/volume] in Blood

682

5230

1.31

10.27

7.5

6.8

105.15

105.21

mmol/l

0.13

621

4709

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

474

2.05

10.07

1.4

32.26

22.19

2.21

406

(3023383) Lactate [Moles/volume] in Pleural fluid

114

590

1.93

10.07

1.3

3.68

3.41

mmol/l

0.39

104

548

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

542

4036

1.35

10.02

1.1

4.00

3.08

u/ml

0.43

183

2021

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

282

1868

1.51

10.00

1.9

1.7

—

(3002619) Bacteria identified in Specimen by Culture

101

503

2.01

9.96

1.5

1.2

—

(3005033) Fetal Nuchal fold Thickness US

409

5670

0.72

9.96

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

3233

28840

1.13

9.91

1.5

1.4

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

140

3.00

9.90

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

3064

27244

1.14

9.88

1.6

1.7

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

100

3.40

9.82

2.2

1.4

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

3.61

9.77

1.3

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

101

507

1.99

9.76

1.3

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

411

5673

0.72

9.75

1.4

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.97

9.73

3.7

3.4

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

101

508

1.99

9.70

1.3

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

101

508

1.99

9.70

1.3

1.1

—

(3027035) Albumin [Mass/time] in 24 hour Urine

203

2.61

9.68

1.6

1.2

213.50

302.68

mg/24h

—

(3024316) Viscosity of Plasma

106

3.30

9.67

1.2

1.6

1.66

1.53

mpas

0.47

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

3.66

9.66

1.0

1.1

1.18

1.34

u/field

0.16

(40757494) Bilirubin.total [Moles/volume] in Blood

206

1283

1.61

9.61

2.6

2.3

28.72

32.43

umol/l

0.10

123

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

216

2.55

9.55

1.3

1.42

1.61

ml/s/173m2

0.20

148

(3043238) Trisomy 21 risk [Likelihood] in Fetus

426

5814

0.73

9.43

1.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

303

2.28

9.40

1.2

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

160

940

1.70

9.37

2.7

2.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

374

2.14

9.36

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1305

10902

1.21

9.32

2.1

2.3

6846.59

5449.87

u/l

0.58

412

4283

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

219

2.51

9.30

1.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

219

1398

1.57

9.23

1.4

1.2

235.62

328.05

u/l

1.39

204

1301

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

140

797

1.76

9.18

1.3

1.2

26.25

19.46

0.47

133

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1040

8516

1.23

9.11

3.5

400.18

2186.09

u/ml

1.53

890

7293

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

211

2.51

8.98

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

572

7427

0.77

8.97

1.4

1.5

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

297

2.26

8.95

1.2

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

160

2.75

8.91

1.2

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

133

2.93

8.87

1.3

1.7

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

268

2.31

8.79

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

4.00

8.76

6.6

8.6

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

127

714

1.78

8.72

1.4

1.7

—

381.50

iu/ml

—

(3035320) C reactive protein [Mass/volume] in Body fluid

278

1893

1.47

8.69

2.8

2.3

—

(3006969) Lambda light chains [Mass/volume] in Urine

4.75

8.56

1.1

0.20

0.02

g/l

—

(3002523) Influenza virus A Ag [Presence] in Specimen

583

4493

1.30

8.55

1.1

—

(3004775) Volume in Urine collected for unspecified duration

268

1820

1.48

8.50

2.5

2.3

771.56

664.33

3.02

198

1268

(3003740) Influenza virus B Ag [Presence] in Specimen

583

4497

1.30

8.50

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

26253

258269

1.10

8.42

4.4

4.2

4.64

4.73

mmol/l

43.35

24717

241556

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

171

2.63

8.40

1.2

1.0

—

(3026470) Cobalt [Mass/volume] in Blood

207

1335

1.55

8.39

2.0

3.55

3.59

ug/l

0.03

188

1224

(3025577) Chromium [Mass/volume] in Blood

202

1301

1.56

8.25

2.0

2.1

2.20

2.42

ug/l

0.41

167

1082

(4212803) Bone marrow aspirate examination

185

2.54

8.18

1.0

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

297

2.19

8.11

1.3

0.81

1.58

mmol/l

0.83

186

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

158

2.66

8.01

1.1

—

(3020618) Glucose [Moles/volume] in Synovial fluid

3.62

7.98

1.1

5.08

5.16

mmol/l

0.04

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

4.12

7.97

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

211

3151

0.67

7.88

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

502

6498

0.77

7.75

1.5

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

281

1968

1.43

7.64

1.2

1.3

1.34

1.88

u/ml

0.52

151

1109

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.38

7.49

1.0

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

399

2979

1.34

7.39

2.5

1.9

28.69

25.25

mg/l

0.55

119

788

(3020650) Glucose [Presence] in Urine

118

684

1.73

7.37

1.6

1.4

—

(3036180) Methadone [Presence] in Urine

1502

0.54

7.35

2.2

2.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

485

3728

1.31

7.33

3.1

0.81

nmol/l

0.07

364

2874

(40768793) Breast Pathology biopsy report

480

6197

0.77

7.29

1.3

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

143

2.66

7.27

1.0

1.2

1.21

1.16

u/field

0.06

(3017400) Magnesium [Moles/volume] in Urine

3.82

7.23

1.1

3.31

3.18

mmol/l

0.07

(3001019) Free T4 and TSH panel - Serum or Plasma

1319

15341

0.85

7.19

1.7

—

(3003129) Base excess in Capillary blood by calculation

104

586

1.78

7.18

1.9

1.6

0.54

0.69

mmol/l

0.13

546

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

256

2.19

7.04

1.2

1.3

621.13

219.58

u/l

0.29

184

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

268

1894

1.42

6.98

2.0

1.98

2.18

u/field

0.21

129

850

(3046914) Granular casts [#/area] in Urine by Computer assisted method

4.36

6.94

1.2

1.5

0.70

0.61

u/field

—

(46236302) HLA-C [Type] by High resolution typing

3.04

6.86

1.0

—

(40762365) Oxygen content in Arterial blood by calculation

380

1.95

6.84

3.1

3.0

15.10

14.79

ml/dl

0.34

355

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

132

808

1.64

6.76

1.2

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

144

2.57

6.66

1.3

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

378

1.93

6.61

1.3

1.2

1.94

1.73

mmol/l

0.45

225

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

250

2.16

6.60

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

402

5232

0.76

6.55

2.3

3.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

236

1653

1.43

6.49

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1104

9401

1.18

6.48

1.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

158

1021

1.55

6.47

2.1

2.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

112

2.77

6.44

1.1

1.2

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

3.50

6.41

1.0

1.1

—

(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

+∞

6.25

4.0

0.0

—

(40760410) HLA-B [Type] by High resolution

2.94

6.24

1.0

—

(40763590) HLA-DQ beta [Type]

2.94

6.24

1.0

—

(40760409) HLA-A [Type] by High resolution

2.94

6.24

1.0

—

(3030313) Adrenal Ab [Titer] in Serum

252

2.10

6.09

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

133

2062

0.64

6.07

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

182

2.31

6.04

1.2

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

2.87

6.02

1.1

1.2

0.07

g/l

0.03

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

3.58

6.02

1.2

1.1

—

(3006270) Folate [Moles/volume] in Blood

268

1952

1.38

5.92

1.2

1.1

354.94

373.78

nmol/l

0.81

236

1682

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

3.39

5.84

5.1

5.2

9.16

5.10

mg/l

0.51

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

191

1316

1.45

5.80

1.6

2.0

176.98

137.11

6.99

179

1236

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

26556

262172

1.08

5.76

4.7

2.71

2.82

mmol/l

79.96

24880

244014

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

26001

256489

1.08

5.75

4.3

4.2

1.50

1.47

mmol/l

20.29

24371

238905

(4281824) Cell count and differential, peritoneal fluid

211

2953

0.71

5.66

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

1459

0.59

5.60

1.3

1.4

30.15

30.85

nmol/l

0.08

1321

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

106

650

1.63

5.48

1.3

121.13

129.59

nmol/l

0.24

473

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

255

1869

1.37

5.46

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

177

1217

1.46

5.46

1.1

93.77

98.32

1.36

145

961

(40768800) Prostate Pathology biopsy report

303

3987

0.76

5.44

1.2

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

147

2.38

5.43

1.1

1.82

3.35

u/l

—

(3019977) pH of Arterial blood

181

1252

1.45

5.41

2.8

2.5

7.43

7.42

0.30

410

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

308

2327

1.33

5.41

2.3

21.28

19.18

nmol/l

2.30

292

2207

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.95

5.39

1.0

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

1040

12034

0.86

5.39

1.7

2.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

293

0.24

5.36

8.0

7.4

—

(3041184) Isoniazid [Presence] in Urine

5.60

5.36

2.6

2.8

—

(3013862) HLA-DP [Type]

2.74

5.34

1.0

—

(3028300) Cannabinoids [Presence] in Urine

1050

12132

0.86

5.34

1.7

2.2

—

(3027944) Amphetamines [Presence] in Urine

1029

11901

0.86

5.30

1.7

2.1

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

110

1721

0.64

5.30

11.0

12.2

0.63

0.62

mmol/l

0.08

1589

(3027008) Opiates [Presence] in Urine

1048

12102

0.86

5.29

1.7

2.1

—

(3008295) Osmolality of Serum or Plasma

317

2415

1.32

5.26

1.4

1.5

278.55

280.41

mosm/kgh2o

0.71

250

1886

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

382

4852

0.78

5.23

1.4

1.5

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

261

1.99

5.23

4.2

2.9

1.91

1.20

mg/l

0.58

181

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

3.04

5.20

1.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

368

1.82

5.16

1.3

37.93

42.05

mg/l

0.36

313

(3003338) MCHC [Mass/volume]

23201

228209

1.06

5.13

34.8

15.6

331.18

332.77

g/l

133.06

23111

226581

(3016879) Cocaine [Presence] in Urine

968

11211

0.86

5.10

1.8

2.2

—

(40768795) Lymph node Pathology biopsy report

327

2515

1.30

5.08

1.2

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

8.33

5.05

1.0

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

25124

247790

1.07

5.03

4.0

3.8

1.30

mmol/l

0.21

23454

229224

(3039443) Prostate specific Ag panel - Serum or Plasma

338

4330

0.78

4.99

1.6

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

552

1.65

4.96

1.3

372.60

314.55

ug/l

0.07

301

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

226

2.04

4.93

1.4

57.68

72.97

2.10

195

(3011985) Renin [Units/volume] in Plasma

446

3583

1.25

4.88

1.6

1.5

71.50

63.87

mu/l

0.38

395

3194

(1001926) Buprenorphine [Presence] in Urine by Screen method

797

9334

0.85

4.86

1.8

2.3

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

135

904

1.49

4.81

1.1

96.19

91.28

0.71

414

(3050794) Legionella sp Ab [Presence] in Serum

203

2.07

4.71

1.1

1.2

—

(3003694) ABO and Rh group [Type] in Blood

7781

74449

1.06

4.57

1.5

—

(3011288) Drugs identified in Urine by Screen method

689

8115

0.85

4.53

2.3

3.0

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

10.00

4.51

1.0

1.1

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

10.00

4.51

1.0

1.1

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

174

2.13

4.47

1.6

1.9

189.43

167.15

ug/g

0.29

149

(3025130) Human papilloma virus identified in Specimen

478

3910

1.23

4.47

1.9

1.7

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

485

5889

0.82

4.46

1.8

1.7

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

136

928

1.47

4.45

1.1

95.43

90.73

0.94

419

(3014271) Vancomycin [Susceptibility]

148

1031

1.44

4.36

2.8

2.9

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

138

949

1.46

4.35

1.1

1.2

114.13

108.00

0.92

128

853

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

526

1.62

4.34

1.8

2.7

—

(3015350) Toxocara sp Ab [Presence] in Serum

4.48

4.23

1.0

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

593

1.57

4.20

1.1

1.2

85.54

88.36

0.21

163

(3046682) IgA [Presence] in Skin by Immunofluorescence

4.12

4.19

1.0

1.1

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

4.80

4.17

2.0

2.5

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

124

845

1.47

4.12

1.1

2.88

7.09

u/ml

0.52

501

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

187

2.03

4.11

1.1

49.77

9.96

iu/ml

1.32

(40758047) Lysozyme [Mass/volume] in Pleural fluid

181

2.04

4.07

1.1

9.75

10.05

mg/l

0.06

165

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

141

988

1.43

4.05

1.2

0.32

0.30

g/l

1.44

118

787

(3012898) Urea [Moles/volume] in Urine

251

1.87

4.03

1.2

1.5

190.19

168.92

mmol/l

0.48

229

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

739

6368

1.16

3.91

1.2

1.3

—

(3006462) Nitrate [Presence] in Urine

168

1222

1.38

3.91

5.4

2.7

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

404

3304

1.23

3.85

1.4

331.17

400.34

pmol/l

0.82

353

2889

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

139

982

1.42

3.84

1.7

2.0

200.92

160.05

3.30

132

931

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

131

1847

0.71

3.83

1.5

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

3.94

3.78

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

3.94

3.78

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

3.94

3.78

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

3.94

3.78

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

3.94

3.78

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

3.94

3.78

2.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

475

1.60

3.78

1.6

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2654

24666

1.08

3.67

3.3

4.1

19.12

24.97

ug/l

0.51

2068

19700

(3033942) Copper [Moles/time] in 24 hour Urine

116

2.24

3.62

1.1

0.34

0.75

umol/24h

0.82

(43055442) Apixaban [Mass/volume] in Serum or Plasma

283

1.77

3.60

1.3

1.5

138.93

105.54

ug/l

1.14

234

(3027570) Oxalate [Moles/time] in 24 hour Urine

150

2.07

3.55

1.3

1.4

324.52

327.57

umol/24h

0.03

150

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

395

0.40

3.47

1.2

—

(44813793) Dust mix specific IgE antibody measurement

257

2024

1.27

3.47

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

130

927

1.40

3.46

1.5

1.4

14.96

14.87

pmol/l

0.08

114

774

(3027974) Hepatitis B virus e Ag [Presence] in Serum

159

2.01

3.43

1.1

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

279

2226

1.26

3.39

3.1

3.0

50.42

47.46

mg/l

0.09

222

1566

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1335

14732

0.90

3.39

2.4

3.4

45.60

51.51

u/ml

0.45

1276

14236

(3009214) Lutropin [Units/volume] in Serum or Plasma

939

8328

1.13

3.34

1.5

1.4

10.84

10.11

u/l

0.83

778

6772

(3028468) Fragments [Presence] in Blood by Light microscopy

5.71

3.33

1.0

2.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

830

7305

1.14

3.33

1.8

1.7

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

283

1.73

3.33

2.6

2.5

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

161

1.99

3.32

1.0

1.1

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

175

1.94

3.31

1.1

1.2

25.17

21.09

0.20

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

352

1.65

3.29

1.3

1.4

56.66

53.15

0.22

177

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

3.93

3.28

1.6

1.4

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

162

1.98

3.27

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

234

1837

1.28

3.27

1.1

9.60

8.16

iu/ml

0.23

471

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

277

2220

1.25

3.25

1.4

1.3

1.57

1.42

nmol/l

1.55

251

2000

(3027874) Urate [Moles/volume] in Urine

2.50

3.20

1.0

1.1

1.68

1.72

mmol/l

0.03

(3000919) Neutrophils/100 leukocytes in Pleural fluid

537

1.51

3.17

1.4

1.3

34.59

20.54

3.47

497

(3032743) Legionella sp IgG Ab [Presence] in Serum

157

1.97

3.17

1.1

—

(3018291) Platelet Ab [Presence] in Serum

3.43

3.09

1.0

—

(3024869) Neuronal Ab [Presence] in Serum

429

1.56

3.08

1.0

1.1

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

4.00

3.08

1.0

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

973

0.65

3.05

2.5

3.0

27.57

28.36

umol/l

0.30

736

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

102

715

1.43

3.03

1.4

49.09

63.62

3.20

599

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

1328

0.70

3.02

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

353

1.62

3.02

1.0

0.04

0.26

u/ml

1.42

219

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

147

1.97

2.98

1.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

761

6721

1.14

2.94

2.2

1.8

4.39

13.22

iu/l

1.40

269

2537

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

596

1.46

2.93

1.1

1.2

69.67

75.77

0.56

159

(3001893) Eosinophils/100 leukocytes in Pleural fluid

598

1.46

2.89

1.4

3.73

2.72

0.38

516

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

2061

19209

1.08

2.72

1.2

119.00

145.58

iu/ml

2.67

743

7249

(3027231) Wheat IgE Ab [Units/volume] in Serum

592

1.44

2.67

1.0

1.1

1.72

2.69

u/ml

0.30

502

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

408

3475

1.18

2.64

1.3

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

155

1.87

2.59

1.1

1.5

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

114

2.02

2.55

1.2

1.6

0.17

0.03

u/l

0.34

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

146

1119

1.31

2.54

1.9

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

907

10042

0.90

2.54

1.7

1.9

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

354

1.55

2.54

1.3

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

122

913

1.34

2.52

1.2

112.55

111.59

0.14

106

819

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

3.46

2.47

1.2

1.3

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

3.46

2.47

1.2

1.3

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

165

1.82

2.47

1.3

18.19

17.32

pmol/l

0.11

139

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

3.81

2.46

9.1

2.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1865

17401

1.08

2.42

3.1

3.4

4.43

4.51

pmol/l

2.00

1670

15552

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

647

5738

1.13

2.42

2.6

2.3

84.40

110.65

ug/min

1.44

366

3459

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

253

2092

1.21

2.33

1.8

1.5

0.91

0.95

g/l

2.13

253

2082

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

3704

38736

0.95

2.29

2.8

2.9

0.68

0.74

ug/l

2.54

2440

24571

(3032641) Amino acids panel - Urine

2.94

2.27

1.3

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

25262

250445

1.04

2.25

4.3

5.80

5.88

mmol/l

22.20

23407

230709

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

318

3737

0.85

2.24

1.4

1.3

3.03

3.88

ug/l

1.48

285

3288

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

513

1.42

2.24

1.3

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

216

1.67

2.23

1.1

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

431

1.46

2.23

5.4

2.3

1.20

1.19

mmol/l

0.39

417

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

3.10

2.22

1.0

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

232

1.64

2.21

1.1

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.33

2.21

1.1

1.2

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

100

2.00

2.19

1.2

1.3

1.20

1.14

u/field

—

(40760512) CD34 cells/100 cells in Bone marrow

4.28

2.15

1.5

1.7

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

148

1168

1.27

2.12

1.5

2.1

114.23

136.09

umol/l

0.33

577

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

324

3780

0.86

2.11

1.4

1.3

7.28

7.12

mmol/l

0.42

297

3362

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

123

1.87

2.10

1.1

1.3

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.21

2.10

1.1

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

210

1727

1.22

2.08

1.0

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

126

977

1.29

2.08

2.2

2.7

1.32

1.18

ug/l

0.36

119

920

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

520

0.61

2.06

1.3

1.2

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

2.07

2.06

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

154

1.75

2.02

1.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

429

3756

1.14

2.02

1.2

1.3

0.61

1.35

nmol/l

1.06

413

3614

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

170

1.71

1.99

1.0

1.1

14.03

8.64

u/l

0.25

170

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1061

9773

1.09

1.97

1.5

1.4

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

3.33

1.96

1.0

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

427

3749

1.14

1.94

1.2

1.3

0.24

0.23

nmol/l

0.08

236

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

134

1.79

1.94

1.1

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

4.54

1.94

1.2

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

4.54

1.94

1.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

726

0.69

1.92

3.3

3.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

725

0.69

1.91

6.7

6.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

174

2121

0.82

1.90

1.3

151.86

190.52

pmol/l

1.97

174

2121

(3006576) Bicarbonate [Moles/volume] in Blood

109

844

1.29

1.86

6.0

6.6

24.21

25.13

mmol/l

2.04

775

(40765089) Chromosome analysis panel - Blood by G-banded

873

0.72

1.86

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

2.86

1.86

1.1

1.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

122

959

1.27

1.85

2.4

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

159

1.70

1.84

1.0

22.65

17.65

u/ml

0.20

134

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

340

2952

1.15

1.84

1.2

18.86

32.22

nmol/l

—

(3002079) Sodium [Moles/time] in 24 hour Urine

154

1246

1.24

1.83

1.3

1.2

149.99

160.38

mmol/24h

0.95

154

1246

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

120

1515

0.79

1.82

1.5

2.0

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

3.04

1.79

1.0

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

589

6528

0.90

1.79

1.4

130.75

133.47

pmol/l

0.04

571

6376

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

123

1.79

1.1

—

(4146454) Self-monitoring of blood glucose

220

2604

0.84

1.77

2.7

2.8

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

105

1336

0.78

1.72

1.1

1.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

756

0.71

1.72

1.6

1.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

485

5410

0.89

1.68

4.2

3.2

27.63

26.38

mg/l

0.34

291

3386

(40762814) Titanium [Mass/volume] in Blood

392

1.40

1.64

2.3

3.90

3.80

ug/l

0.06

131

(3027540) Rickettsia typhi Ab [Titer] in Serum

2.44

1.64

1.1

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

2.03

1.64

1.0

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

112

1.79

1.63

1.1

1.0

0.25

0.08

u/ml

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

351

1.42

1.63

1.0

—

(3007733) Chloride [Moles/volume] in Urine

2.03

1.53

1.5

1.7

103.00

80.09

mmol/l

0.72

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

624

1.30

1.50

8.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1073

10021

1.07

1.48

1.6

1.7

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

381

3394

1.12

1.46

1.2

1.3

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

2.50

1.45

1.1

1.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

3555

34314

1.04

1.44

1.6

1.8

1.49

1.42

6.25

3104

30436

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

164

1.59

1.42

1.0

1.2

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

295

1.42

1.40

1.0

0.64

0.09

u/ml

1.26

182

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

2.41

1.39

1.0

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

127

1.65

1.36

1.0

0.23

0.13

u/ml

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

346

0.64

1.33

2.2

3.5

39.88

40.78

umol/l

0.07

300

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.91

1.33

1.0

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

163

1379

1.18

1.32

1.4

1.6

1.33

1.23

nmol/l

0.53

126

1089

(3018738) Hemoglobin F/Hemoglobin.total in Blood

193

1.50

1.28

5.4

3.4

15.87

9.96

0.53

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

169

1.54

1.28

5.7

4.7

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.04

1.26

1.1

—

(3022689) Creatine [Moles/volume] in Urine

749

1.24

1.25

1.7

1.5

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

669

1.26

1.25

2.3

2.7

101.55

115.47

ng/l

0.50

355

(3021387) Prolactin [Units/volume] in Serum or Plasma

961

10234

0.94

1.23

1.6

286.95

312.96

mu/l

1.82

859

9250

(44786800) Granulocytes/100 leukocytes in Body fluid

253

1.42

1.23

1.3

35.81

22.51

1.28

194

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

106

869

1.22

1.0

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

580

5341

1.09

1.21

2.0

1.9

196.31

196.75

pmol/l

0.04

551

5079

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

296

1.38

1.21

1.0

—

(3014891) Appearance of Pleural fluid

246

1.42

1.20

1.1

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

6853

67084

1.03

1.19

4.2

4.6

2.24

2.91

ug/l

3.20

6159

60646

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

169

0.53

1.18

1.0

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

199

1.46

1.13

1.3

1.5

33.77

35.66

0.09

134

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

152

1768

0.86

1.11

1.1

1.3

1.61

1.55

g/l

1.72

152

1768

(3001218) Citrate [Mass/time] in 24 hour Urine

2.26

1.10

1.9

1.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

5220

53403

0.97

1.10

3.8

4.0

21.59

21.84

0.52

2421

24419

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

135

1582

0.85

1.09

1.0

332.50

332.95

ng/l

0.00

101

1118

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

1.95

1.08

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

558

1.25

1.07

8.3

8.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

506

1.26

1.05

1.2

1.9

2.81

2.76

ug/l

0.02

303

(3026692) Albumin [Mass/volume] in Peritoneal fluid

570

1.25

1.03

1.5

1.4

11.53

13.54

g/l

0.97

437

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

291

1.34

0.98

1.5

1.4

12.44

13.30

0.08

150

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

413

0.73

0.98

1.0

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

426

4621

0.92

0.96

1.2

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

146

1270

1.15

0.92

3.1

2.1

201.71

202.24

u/l

0.03

146

1261

(3023511) Choriogonadotropin [Units/volume] in Urine

592

5537

1.07

0.90

1.4

1.3

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

151

1.46

0.90

2.3

6.23

19.65

3.39

(3012989) Citrate [Moles/time] in 24 hour Urine

1.90

0.88

1.9

1.4

2.16

2.07

mmol/24h

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

194

1.39

0.87

2.4

2.2

55.32

58.71

0.16

116

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.58

0.87

1.1

1.2

249.53

270.09

nmol/l

0.29

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

139

1588

0.87

0.85

1.0

800.34

740.37

ng/l

0.78

101

1083

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

468

1.24

0.85

2.2

2.3

8.16

7.49

mmol/l

0.27

268

(3036312) Salmon IgE Ab [Units/volume] in Serum

170

1.41

0.84

1.0

1.1

1.21

1.92

u/ml

0.24

128

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

105

1.52

0.81

5.6

10.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.60

0.81

1.1

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.70

0.80

1.3

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

535

1.21

0.80

1.3

1.4

—

(3018001) Oat IgE Ab [Units/volume] in Serum

189

1.38

0.80

1.0

0.64

0.21

u/ml

0.70

116

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

140

1589

0.88

0.80

1.0

39.76

42.21

ng/l

0.29

102

1103

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

122

1.47

0.79

8.6

11.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

204

1835

1.11

0.79

1.1

8.89

2.26

u/ml

0.53

637

(3019298) Eosinophils/100 leukocytes in Peritoneal fluid

1.67

0.78

1.3

1.5

0.43

0.39

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

628

1.19

0.78

1.2

435.22

300.92

pmol/l

0.68

461

(3013336) Amino acids [Identifier] in Serum or Plasma

1.53

0.78

1.5

2.9

—

(3008037) Lactate [Moles/volume] in Venous blood

513

4806

1.07

0.78

3.8

3.0

1.46

1.57

mmol/l

2.81

495

4707

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

234

1.32

0.77

2.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

135

1525

0.88

0.73

1.4

5.46

5.69

mmol/l

1.52

124

1439

(3013139) Helicobacter pylori Ag [Presence] in Stool

1748

18043

0.97

0.72

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

147

1308

1.12

0.71

2.9

6.1

4428.29

3027.43

u/ml

—

275

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

308

2846

1.08

0.70

1.0

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

282

1.28

0.70

1.1

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

198

1795

1.10

0.69

1.1

4.20

4.78

u/ml

0.07

479

(3020191) Ethanol [Moles/volume] in Serum or Plasma

206

2261

0.91

0.68

1.3

1.5

1.18

1.42

promille

1.56

158

1711

(3014133) Dog dander IgE Ab [Units/volume] in Serum

392

4189

0.93

0.67

1.1

4.40

4.32

u/ml

0.03

185

2031

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

180

1.33

0.64

1.3

1.2

90.90

109.25

ug/l

0.36

114

(3002331) Protein [Mass/volume] in Peritoneal fluid

504

1.19

0.64

1.3

1.4

22.59

29.17

g/l

1.15

391

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

287

1.25

0.63

1.1

0.12

1.97

u/ml

0.85

158

(3003888) Timothy IgE Ab [Units/volume] in Serum

503

5313

0.95

0.62

1.1

5.38

5.35

u/ml

0.01

257

2806

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

104

0.58

0.61

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

105

0.57

0.61

1.2

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

357

0.78

0.61

2.0

2.6

56.75

77.53

pmol/l

0.56

307

(3044590) Delta aminolevulinate [Moles/volume] in Urine

0.00

0.60

0.0

1.0

—

15.24

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

411

0.80

0.59

1.0

84.95

80.17

ug/l

0.32

336

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

201

1.29

0.58

1.0

0.98

1.55

u/ml

0.22

141

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

175

1.31

0.57

1.0

1.1

21.89

6.78

u/ml

0.66

127

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

282

1.24

0.57

1.1

0.07

0.86

u/ml

1.42

161

(3046904) Somatotropin [Units/volume] in Serum or Plasma

1.48

0.57

1.4

2.2

1.96

2.76

mu/l

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

360

3384

1.06

0.56

1.4

1.7

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

451

0.82

0.56

1.2

1.6

4.88

5.40

nmol/l

0.19

431

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

116

1038

1.12

0.55

1.0

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

105

1177

0.89

0.55

2.0

2.1

48.63

123.42

ug/min

1.38

254

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

522

1.17

0.55

1.1

3.22

6.14

u/ml

0.64

382

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.54

0.55

1.2

1.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

369

3915

0.94

0.55

1.0

1.1

3.53

4.97

u/ml

1.27

151

1651

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

187

2034

0.92

0.55

1.6

7.85

7.78

mmol/l

0.15

180

1951

(3017509) Phencyclidine [Presence] in Urine

351

0.80

0.54

1.9

2.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1.58

0.54

1.0

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.41

0.54

1.1

1.3

501.60

482.05

nmol/l

0.07

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

888

0.88

0.53

1.0

8.62

10.71

u/ml

0.43

503

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

276

2577

1.07

0.53

4.2

4.8

101.11

116.85

u/ml

0.18

815

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

215

0.74

0.52

1.9

3.0

4675.00

55.41

pmol/l

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

259

1.24

0.52

1.1

0.44

0.37

u/ml

0.09

149

(3013762) Body weight Measured

0.61

0.51

1.0

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.41

0.51

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

1062

0.89

0.50

1.8

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

659

1.14

0.50

1.8

1.7

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1515

14747

1.03

0.49

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

138

1511

0.91

0.49

1.3

—

(3009677) Dengue virus Ab [Presence] in Serum

110

1.36

0.48

1.1

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

218

1.24

0.46

1.1

1.0

—

(3003577) Lead [Moles/volume] in Blood

220

0.77

0.44

1.8

1.4

0.22

0.23

umol/l

—

(3041354) Potassium [Moles/volume] in Venous blood

282

2657

1.06

0.44

2.9

2.3

4.05

4.04

mmol/l

0.15

277

2637

(4094501) Cardiovascular stress test using bicycle ergometer

671

6958

0.96

0.43

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

211

1.23

0.43

1.0

1.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

517

1.14

0.43

1.3

7.28

1.42

u/ml

0.41

512

(3029396) Erythrocyte agglutination [Presence] in Blood

755

0.89

0.42

2.9

2.8

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

185

1723

1.07

0.42

2.3

3.4

149.87

128.62

nmol/l

0.23

174

1703

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

138

1271

1.09

0.41

1.2

1.1

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

0.41

0.0

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

380

0.84

0.40

3.8

5.8

—

(3006598) pH of Arterial cord blood

172

0.76

0.40

1.1

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

314

1.18

0.40

2.9

2.3

0.78

0.61

u/field

0.42

314

(3040794) Aluminum [Moles/volume] in Urine

1.47

0.40

1.0

1.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

534

5137

1.04

0.39

3.0

2.0

0.99

0.82

nmol/l

4.28

464

4305

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

324

0.83

0.39

1.2

—

(3035285) Chloride [Moles/volume] in Venous blood

280

2656

1.05

0.38

2.9

2.3

105.52

105.60

mmol/l

0.10

275

2636

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

410

1.15

0.38

8.0

7.1

—

(3008607) Semen analysis panel

214

0.79

0.37

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

439

4212

1.04

0.37

1.1

47.46

2980.05

iu/ml

0.67

106

946

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

112

0.71

0.37

1.0

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

4695

46410

1.01

0.36

1.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

488

5064

0.96

0.36

1.1

2.10

1.05

u/ml

1.06

211

2224

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

322

3369

0.95

0.35

1.0

1.1

0.94

0.38

u/ml

0.69

928

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

3117

30744

1.01

0.33

4.0

4.4

33.41

32.13

8.76

2399

21489

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

125

1342

0.93

0.33

1.1

11.92

8.94

u/ml

0.23

234

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.69

0.33

1.2

1.1

—

(3038515) Glucose [Moles/volume] in Venous blood

468

4514

1.04

0.32

3.9

3.1

7.15

7.51

mmol/l

2.19

454

4430

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

275

1.16

0.32

2.0

—

(3016031) Almond IgE Ab [Units/volume] in Serum

201

1.19

0.32

1.1

1.0

0.64

0.90

u/ml

0.25

121

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

163

1731

0.94

0.32

1.8

1.7

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

316

0.85

0.31

15.3

6.9

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

478

4943

0.97

0.31

1.1

2.33

1.93

u/ml

0.32

260

2522

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.35

0.31

1.0

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1560

15312

1.02

0.31

1.8

1.9

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

283

0.85

0.30

1.0

1.1

1.74

1.75

umol/24h

0.04

283

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

513

1.11

0.30

1.2

141.74

32.70

mg/l

0.50

372

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

100

0.70

0.30

1.1

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

120

1.25

0.30

2.1

3.3

—

0.00

—

(3049233) Organic acids panel - Urine

1.27

0.30

1.1

—

(1002224) Polysomnography panel

1147

11702

0.98

0.29

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

107

996

1.07

0.29

8.0

9.4

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

167

1579

1.06

0.28

1.2

1.3

3.66

4.93

umol/l

5.12

148

1450

(3020491) Glucose [Moles/volume] in Blood

203

1931

1.05

0.28

1.9

1.8

6.64

6.70

mmol/l

0.12

158

1402

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

181

1718

1.05

0.27

1.3

1.5

—

(3034614) HLA Ag [Interpretation]

1.21

0.26

1.1

1.2

—

(3044007) Cell count panel - Peritoneal fluid

674

1.08

0.25

2.3

1.9

—

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

1.23

0.25

1.0

1.2

278.22

401.03

pmol/l

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

245

0.86

0.25

1.3

1.2

45.85

46.48

mg/l

—

(3001556) Androgen free Index in Serum or Plasma

298

0.87

0.25

1.2

1.3

—

(3022475) Manganese [Moles/volume] in Blood

180

0.83

0.24

1.4

1.2

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.28

0.24

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

539

5252

1.03

0.23

1.6

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

456

1.10

0.23

7.4

5.7

68.68

69.32

0.07

362

(3033705) Calcium.ionized [Moles/volume] in Venous blood

271

2613

1.04

0.23

3.0

2.3

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

514

1.09

0.23

2.1

1.5

0.19

0.23

nmol/l

0.48

372

(40758358) Immune stain study

125

0.80

0.23

1.0

—

(36303858) Crystals [Presence] in Urine

1.28

0.23

1.2

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1891

18664

1.01

0.22

2.2

12.78

12.46

nmol/l

1.02

1720

16861

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

361

3719

0.97

0.22

1.5

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.22

0.22

1.0

—

(3013931) Oligosaccharides [Presence] in Urine

0.00

0.21

0.0

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

565

1.08

0.21

1.1

0.61

0.81

umol/24h

0.89

284

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

183

1.15

0.20

1.0

2.43

1.10

u/ml

0.43

141

(3029612) Listeria sp Ab [Titer] in Serum

1.22

0.20

1.0

1.3

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.22

0.20

2.0

2.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

136

1.18

0.20

1.1

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

176

0.85

0.20

1.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

433

4435

0.98

0.19

1.5

0.35

0.39

nmol/l

0.46

324

3433

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.22

0.19

1.0

1.1

151.00

225.33

pmol/l

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.15

0.19

1.0

1.1

2.33

2.63

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

540

0.93

0.19

1.5

1.9

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

241

1.12

0.19

1.2

13.80

15.61

nmol/l

—

(46235168) Fasting glucose [Moles/volume] in Blood

301

0.90

0.18

1.2

2.0

5.49

7.40

mmol/l

—

101

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

290

0.90

0.18

1.0

1.3

—

1.67

mmol/l

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

1.17

0.17

1.0

1.5

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

462

4519

1.02

0.17

1.3

1.4

27.57

27.45

u/l

0.02

384

3706

(3042517) Benzodiazepines panel - Urine

382

0.92

0.17

2.5

2.9

—

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

1.22

0.17

1.0

0.01

0.23

u/ml

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

1450

14329

1.01

0.17

1.4

28.35

27.96

iu/l

0.16

1245

12324

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

349

1.09

0.17

2.2

2.5

1.25

1.31

mmol/l

0.04

244

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

167

1.14

0.16

1.2

1.3

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

122

1272

0.96

0.16

1.6

2.96

9.56

nmol/l

0.83

1063

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

350

1.09

0.16

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.14

0.15

1.0

1.1

—

mmol/l

—

(37021550) Renin [Units/volume] in Plasma --upright

557

1.06

0.14

1.2

1.3

202.37

75.86

mu/l

0.41

420

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

121

1165

1.04

0.14

2.1

2.5

37.99

53.11

umol/l

4.71

106

1010

(3032868) Hemoglobin electrophoresis panel in Blood

243

0.90

0.14

1.5

1.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

714

1.05

0.13

3.1

2.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

714

1.05

0.13

3.1

2.6

—

(1761482) Bacteria [#/volume] in Urine by Culture

588

5788

1.02

0.13

4.6

3.9

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

201

0.90

0.13

1.0

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

315

1.08

0.13

1.0

1.1

1.72

2.60

u/ml

0.32

239

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

281

2869

0.98

0.12

2.4

3.3

6.41

7.88

nmol/l

0.25

269

2775

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

514

1.05

0.10

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

145

1489

0.97

0.10

1.4

1.9

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

580

5869

0.99

0.10

1.1

2.42

2.04

u/ml

0.28

290

3002

(3011335) Digoxin [Mass/volume] in Serum or Plasma

164

1.10

0.09

2.3

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

780

7722

1.01

0.09

1.7

41.43

40.95

nmol/l

0.21

763

7521

(3012403) Metanephrines [Moles/time] in 24 hour Urine

1.04

0.09

1.0

1.1

—

30.32

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

390

1.05

0.08

1.2

1.1

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.82

0.08

1.0

176.00

162.90

g/l

—

(3022670) pH of Venous cord blood

0.81

0.08

1.2

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

371

1.05

0.08

1.2

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

215

1.07

0.07

1.5

1.7

40.74

48.13

umol/l

0.75

215

(3033799) Differential panel - Peritoneal fluid

742

0.97

0.07

2.2

1.9

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

396

0.96

0.06

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

241

2439

0.99

0.06

1.3

8.87

8.32

mmol/l

1.06

231

2344

(3000285) Sodium [Moles/volume] in Blood

286

1.05

0.05

1.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

284

2808

1.01

0.05

1.7

2.0

24.24

24.44

ug/l

0.02

274

2753

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

346

1.04

0.05

1.1

1.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

754

0.98

0.04

2.5

1.9

5277.13

10774.75

e6/l

0.75

409

(3007463) Buprenorphine [Presence] in Urine

131

1.07

0.03

2.3

8.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1927

19297

1.00

0.02

1.9

2.0

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

163

1617

1.01

0.02

1.1

1.0

0.50

1.05

u/ml

0.69

420

(3023487) Leukocytes [#/volume] in Peritoneal fluid

858

1.00

0.00

2.4

2.0

415.52

2749.44

e6/l

1.45

586

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

169

1691

1.00

0.00

5.9

6.6

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

0.96

-0.00

1.4

1.2

—

(3006392) Corynebacterium diphtheriae [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3017830) Gliadin IgG Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3025311) HLA-B [Type]

0.00

-0.00

0.0

1.0

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(1175312) AMPAR1 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3012787) Ethosuximide [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.1

—

301.86

—

(1176058) AMPAR2 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

(3037820) Gliadin IgA Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3003195) risperiDONE [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

(40771459) Voltage-gated potassium channel Ab [Moles/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(43054952) inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

9.4

—

(3028050) Streptolysin O Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint RX_CROHN_2NDLINE and mortality.

Females

Parameter	HR [95% CI]	p-value
RX_CROHN_2NDLINE	1.489 [1.37, 1.62]	< 0.001
Birth year	0.997 [0.99, 1.0]	0.426

During the follow-up period (1.1.1998 — 31.12.2019), 9945 out of 74466 females with RX_CROHN_2NDLINE died.

Males

Parameter	HR [95% CI]	p-value
RX_CROHN_2NDLINE	1.482 [1.35, 1.63]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.01

During the follow-up period (1.1.1998 — 31.12.2019), 7804 out of 50876 males with RX_CROHN_2NDLINE died.

Mortality risk

Mortality risk for people of age

years, who have RX_CROHN_2NDLINE.

N-year risk	Females	Males
1	0.109%	0.213%
5	0.853%	1.45%
10	2.094%	3.974%
15	4.265%	7.84%
20	7.491%	13.469%

Relationships between endpoints

↥

Index endpoint: RX_CROHN_2NDLINE – Second line medication for Crohn's disease

GWS hits: 41

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Second line medication for Crohn's disease

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints